<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id>
<journal-title-group>
<journal-title>PLOS Computational Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1006408</article-id>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-18-00573</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>Antibody-producing cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>Antibody-producing cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>Antibody-producing cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T helper cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Evolutionary immunology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial evolution</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Organismal evolution</subject><subj-group><subject>Microbial evolution</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV infections</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>The low spike density of HIV may have evolved because of the effects of T helper cell depletion on affinity maturation</article-title>
<alt-title alt-title-type="running-head">Affinity maturation drives evolutionary constraints on virus spike density</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8594-6529</contrib-id>
<name name-style="western">
<surname>Amitai</surname>
<given-names>Assaf</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chakraborty</surname>
<given-names>Arup K.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Kardar</surname>
<given-names>Mehran</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Wilke</surname>
<given-names>Claus O.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Texas at Austin, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">kardar@mit.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2018</year>
</pub-date>
<volume>14</volume>
<issue>8</issue>
<elocation-id>e1006408</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Amitai et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pcbi.1006408"/>
<abstract>
<p>The spikes on virus surfaces bind receptors on host cells to propagate infection. High spike densities (SDs) can promote infection, but spikes are also targets of antibody-mediated immune responses. Thus, diverse evolutionary pressures can influence virus SDs. HIV’s SD is about two orders of magnitude lower than that of other viruses, a surprising feature of unknown origin. By modeling antibody evolution through affinity maturation, we find that an intermediate SD maximizes the affinity of generated antibodies. We argue that this leads most viruses to evolve high SDs. T helper cells, which are depleted during early HIV infection, play a key role in antibody evolution. We find that T helper cell depletion results in high affinity antibodies when SD is high, but not if SD is low. This special feature of HIV infection may have led to the evolution of a low SD to avoid potent immune responses early in infection.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>The spike protein on the virus surface mediates its entry to the host cell and a high spike density promotes infection. HIV has a spike density that is almost two orders of magnitude lower than other viruses. This unique feature of HIV has defied explanation since it was first observed. By bringing together theory and computation, rooted in statistical mechanics, with immunology we suggest that the effects of dramatic depletion of T helper cells during HIV infection on antibody production provided an evolutionary driving force for HIV to evolve a low spike density in order to avoid potent immune responses. Additionally, we show that an intermediate spike density induces maximally potent antibody production, a result with implications for vaccine design.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>NSF</institution>
</funding-source>
<award-id>DMR-1708280</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Kardar</surname>
<given-names>Mehran</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Ragon Institute of MGH, MIT, &amp; Harvard</institution>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Chakraborty</surname>
<given-names>Arup K.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>Ragon Institute of MGH, MIT, &amp; Harvard</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8594-6529</contrib-id>
<name name-style="western">
<surname>Amitai</surname>
<given-names>Assaf</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>Financial support for this work was provided by a grant from the Ragon Institute of MGH, MIT, &amp; Harvard (AKC, AA). MK acknowledges support from NSF grant no. DMR-1708280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<page-count count="22"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2018-09-21</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files. The simulation code pertinent can be found in: <ext-link ext-link-type="uri" xlink:href="https://amitaiassaf.github.io/" xlink:type="simple">https://amitaiassaf.github.io/</ext-link>.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Viruses gain entry into their host cells by attaching to specific receptors on the host surface. The proteins that mediate entry comprise the viral spike. Since the host receptor does not mutate rapidly, spike proteins, while often being highly mutable, have conserved regions that bind to elements on the host receptor. For example, the HIV spike protein gp120 contains relatively conserved residues that bind to the CD4 co-receptor on T helper cells. In influenza, the spike is composed of a HA glycoprotein, that attaches to sialyl-oligosaccharide, which is a sugar found in many cell surface proteins [<xref ref-type="bibr" rid="pcbi.1006408.ref001">1</xref>].</p>
<p>From the standpoint of mediating cell entry and thus propagating infection, it is evolutionarily beneficial to exhibit a high concentration of spikes on the virus surface, thus increasing the probability of attaching to host cell receptors [<xref ref-type="bibr" rid="pcbi.1006408.ref002">2</xref>]. But, parts of the proteins that comprise the viral spikes are also the targets (epitopes) of antibodies produced by the humoral immune response. A lower spike density (SD) would hinder antibodies from binding to the same epitope on two spikes on the viral surface simultaneously with its two arms, thus taking advantage of cooperativity of binding by the two arms (avidity) [<xref ref-type="bibr" rid="pcbi.1006408.ref003">3</xref>]. Thus, there is also an evolutionary driving force for viruses to evolve a low SD. But, evasion of potent immune responses may not always favor a low SD. For example, in influenza, hypervariable features at the head of the spike have high immunogenicity. A high SD protects the more conserved domains near the stem from being targeted by antibodies [<xref ref-type="bibr" rid="pcbi.1006408.ref004">4</xref>]. In HIV, the conserved regions are partially protected from the action of antibodies by a shield of glycans or by their membrane-proximal location (a high SD would presumably better shield the latter epitopes). Furthermore, many immunogenic epitopes that do not include any conserved residues are also present on the HIV spike.</p>
<p>Available data indicate that most viruses express a very high number of spikes on their surface. For example, Influenza has around 450 spikes or a SD of 1 spike per 100 nm<sup>2</sup> [<xref ref-type="bibr" rid="pcbi.1006408.ref005">5</xref>], HCV has 250 spikes or SD of 1.73 per 100 nm<sup>2</sup> [<xref ref-type="bibr" rid="pcbi.1006408.ref006">6</xref>]. <xref ref-type="table" rid="pcbi.1006408.t001">Table 1</xref> summarizes much of the available information on SDs of common viruses, and this data shows that HIV is an extreme outlier, exhibiting between 7 and 14 spikes on its surface, resulting in a very low SD of 0.01 spikes per 100 nm<sup>2</sup>, which is 50–100 times lower than that for other viruses [<xref ref-type="bibr" rid="pcbi.1006408.ref007">7</xref>]. So, it appears that most viruses evolved high SDs (presumably enhancing infectivity and possibly distracting the immune system from targeting more conserved epitopes), while HIV has not. If HIV has evolved a low SD to avoid potent antibody responses, why have other viruses not employed the same strategy? If HIV spike proteins were significantly more vulnerable to antibody responses compared to other viruses, this could explain why HIV has evolved a significantly low SD to lower the avidity of antibody binding to epitopes on the spike proteins. But, no evidence exists suggesting that this is true. Another possibility would be that HIV as a retrovirus, has some fundamental architecture constraints on the maximum number of spikes it can display. However, MLV (another retrovirus) has a high surface density [<xref ref-type="bibr" rid="pcbi.1006408.ref008">8</xref>] with at least a hundred spikes on its surface [<xref ref-type="bibr" rid="pcbi.1006408.ref009">9</xref>]. Shedding of the spike (gp120) as an immune decoy could be another reason for the low spike number. However, high spike density viruses such as Ebola also shed their glycoprotein spikes [<xref ref-type="bibr" rid="pcbi.1006408.ref010">10</xref>]. Hence, this mechanism is not sufficient to explain HIV’s uniqueness of low spike density. Thus, an obvious long-standing question remains unanswered: why has HIV evolved to exhibit a significantly lower SD compared to other viruses?</p>
<table-wrap id="pcbi.1006408.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.t001</object-id>
<label>Table 1</label> <caption><title>Diameter and spike density for different viruses.</title> <p>See <xref ref-type="supplementary-material" rid="pcbi.1006408.s001">S1 Text</xref>—“Spike density of different viruses” for details.</p></caption>
<alternatives>
<graphic id="pcbi.1006408.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Virus</th>
<th align="left">Diameter [nm]</th>
<th align="left">Spike number per virion</th>
<th align="left">Surface density [spikes per 100 nm2]</th>
<th align="left">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Influenza A</td>
<td align="left">120</td>
<td align="left">450</td>
<td align="left">1</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref005">5</xref>]</td>
</tr>
<tr>
<td align="left">Herpes Simplex Virus</td>
<td align="left">186</td>
<td align="left">659</td>
<td align="left">0.6</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref062">62</xref>]</td>
</tr>
<tr>
<td align="left">Dengue</td>
<td align="left">41</td>
<td align="left">60</td>
<td align="left">1.13</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref063">63</xref>]</td>
</tr>
<tr>
<td align="left">Zika</td>
<td align="left">60</td>
<td align="left">60</td>
<td align="left">0.53</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref064">64</xref>]</td>
</tr>
<tr>
<td align="left">Hepatitis C virus (HCV)</td>
<td align="left">73</td>
<td align="left">290</td>
<td align="left">1.73</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref006">6</xref>]</td>
</tr>
<tr>
<td align="left">Human immunodeficiency virus (HIV)</td>
<td align="left">120</td>
<td align="left">7–14</td>
<td align="left">0.01</td>
<td align="left">[<xref ref-type="bibr" rid="pcbi.1006408.ref007">7</xref>,<xref ref-type="bibr" rid="pcbi.1006408.ref043">43</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>Upon infection with pathogens, high affinity antibodies develop by a Darwinian evolutionary process called affinity maturation (AM). We inquired if the biology of HIV may influence the effects of SD on AM in a way that is not characteristic of other viruses, and whether this is the underlying reason for a low SD being favored by HIV. To explore this possibility, we developed a coarse-grained computational model of the dynamics of AM.</p>
<p>Results of our calculations show that antibody affinity to the epitopes on the viral spike is a function of its SD for all cases. In particular, highest affinity antibodies are produced for an intermediate SD. To the best of our knowledge, this effect of SD on the resulting Ab affinity has not been reported before. Importantly, we find that the decline in antibody affinity when SD exceeds the optimal value is very gradual, while the affinity declines sharply for SDs below the optimum density. These results suggest that a high SD (beyond the optimum defined above) allows viruses to exhibit high infectivity and evade potent responses directed toward mutationally vulnerable epitopes if they are located at the stem of the spike, while also reducing the affinity of antibodies directed toward the spike. Note, however, that this still allows the immune system to generate reasonably high affinity antibodies as the decline in affinity for SDs higher than the optimum is gradual.</p>
<p>Why is HIV different? Our calculations suggest that the answer lies in a key feature of HIV infection. HIV principally infects T helper cells (CD4 T cells). We find that if T helper cells become extraordinarily limiting during affinity maturation, as is the case immediately following HIV infection, then high spike densities will elicit even higher affinity antibodies—a bad outcome for the virus. We find that this is circumvented if the SD is low. Therefore, our results suggest that a key benefit of a lower SD for HIV is an avoidance of high affinity antibody responses that would otherwise be produced if the SD was high when T helper cell availability becomes much more limiting than usual. However, the tradeoff for having low SD is reduced infectivity [<xref ref-type="bibr" rid="pcbi.1006408.ref011">11</xref>], a long noted feature of this virus. The virus’s low infectivity has not prevented HIV transmission from reaching epidemic proportions; perhaps, because of its high replication rate in infected hosts.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Model description</title>
<p>Antibodies develop in domains within secondary lymphoid organs called germinal centers (GCs), which appear shortly after infection [<xref ref-type="bibr" rid="pcbi.1006408.ref012">12</xref>]. B cells with a moderate threshold affinity for the antigen (Ag) are activated and seed GCs. These B cells then undergo an evolutionary process of mutation and selection that results in B cells with higher affinity receptors as time ensues [<xref ref-type="bibr" rid="pcbi.1006408.ref013">13</xref>]. The AID gene introduces mutations into the B cell receptor (BCR) at a high rate in GCs. The mutated B cells undergo selection against Ag, which is displayed on Follicular dendritic cells (FDC) on immune complexes (IC) [<xref ref-type="bibr" rid="pcbi.1006408.ref014">14</xref>] (<xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1a</xref>). The B cells attempt to capture Ag by forming transient synapses with the FDCs [<xref ref-type="bibr" rid="pcbi.1006408.ref015">15</xref>]. Captured Ag is processed and presented on their surface as peptide-MHC class II complexes. The B cells then compete with each other to bind to T follicular help cells (TfhCs) via interactions between these peptide-MHC complexes and the T cell receptor on the surface of TfhCs. Successful binding results in a survival/proliferation signal. B cells that display more peptide-MHC complexes have an advantage in this competition[<xref ref-type="bibr" rid="pcbi.1006408.ref016">16</xref>]. The majority of positively selected B cells undergo further rounds of mutation and selection [<xref ref-type="bibr" rid="pcbi.1006408.ref017">17</xref>–<xref ref-type="bibr" rid="pcbi.1006408.ref019">19</xref>]. Some of the positively selected B cells differentiate into antibody-secreting plasma cells and memory cells. As time progresses, antibodies with increasing affinity for the Ag are generated.</p>
<fig id="pcbi.1006408.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Extraction of Ag molecules from an immune complex on an antigen-presenting cell.</title>
<p><bold>(a)</bold> A B cell approaches a FDC in order to capture antigen (Ag). The FDC presents an immune complex holding a virus (purple) whose surface is covered by spike proteins (yellow), which are the Ags. The attachment of the virus to the FDC is mediated by low-affinity antibodies (green) bound to receptors, called Fc Receptors (orange, FcR), on the FDC surface. <bold>(b)</bold> Schematic representation of the synapse between the B cell and the FDC (top view). The apparent virus surface is of radius R, where Ag (spike) molecules are distributed. The BCR (black) scans a region, attempting to capture Ag. (<bold>c</bold>) The extraction of antigen molecules from a FDC by a B cell: <bold>(c-i)</bold> A protrusion containing the BCR extends to touch the surface of the FDC displaying Ag molecules. <bold>(c-ii)</bold> Depending on the Ag concentration on the FDC, the BCR may encounter Ag molecules to which it can attach. <bold>(c-iii)</bold> Once a BCR-Ag bond has formed, the B cell pulls on it by applying force mediated by actin. <bold>(c-iv)</bold> Extraction of Ag from FDC can occur. <bold>(d)</bold> Three possible outcomes to the extraction attempt: The initial bond between the BCR and the Ag is severed and no Ag is extracted; the BCR bond holds while the IC-Ag bond breaks and one Ag molecule is extracted; the second arm finds another Ag before the first IC-Ag bond breaks and two Ag molecules are extracted. A scenario where the entire virus+Ab is extracted from the FDC is also feasible and gives similar results in our model.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.g001" xlink:type="simple"/>
</fig>
<p>Affinity maturation has been studied extensively using theoretical models over the last decades, mostly using population dynamics approaches [<xref ref-type="bibr" rid="pcbi.1006408.ref019">19</xref>–<xref ref-type="bibr" rid="pcbi.1006408.ref024">24</xref>] and more recently, using detailed simulation of the dynamics of the immune cells invovled in the GCR [<xref ref-type="bibr" rid="pcbi.1006408.ref025">25</xref>]. To explore how B cell selection and the generation of high affinity Abs depend on Ag concentration and presentation, we constructed a simplified model of Ag capture from the FDCs, and a coarse-grained model of B cell selection in a GC. Thus, our model generalizes previous modeling approaches to include the interaction of the BCR with Ag (spike).</p>
</sec>
<sec id="sec004">
<title>Antigen distribution on FDCs</title>
<p>We are interested in ICs presenting a virus, or a virus fragment (<xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1a</xref>). The Ags of interest are the spike proteins distributed on the virus surface. Assuming that the spikes are distributed on the surface of the virus of radius <italic>R</italic>, with average density <italic>n</italic><sub><italic>Ag</italic></sub>, it contains a total of <italic>M</italic><sub><italic>Ag</italic></sub> = 4<italic>πR</italic><sup>2</sup><italic>n</italic><sub><italic>Ag</italic></sub> spikes (<xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1b</xref>). A virion particle with a radius of 120nm (<xref ref-type="table" rid="pcbi.1006408.t001">Table 1</xref>) with spike density of 0.35 spikes/100nm<sup>2</sup>, has about <italic>M</italic><sub><italic>Ag</italic></sub> = 160 spikes on its surface. During the Ag capture process, BCRs scan for Ag over a region of the synapse and encounter an Ag molecule with probability <italic>p</italic>. We assume that the number <italic>N</italic><sub><italic>Ag</italic></sub> of Ag molecules in the scanning area is distributed randomly, according to the Binomial distribution (<italic>N</italic><sub><italic>Ag</italic></sub> ~ <italic>B</italic>(<italic>M</italic><sub><italic>Ag</italic></sub>, <italic>p</italic>)).</p>
</sec>
<sec id="sec005">
<title>Ag encounter and internalization by the BCR</title>
<p>Consistent with data showing that B cell protrusions that extended toward FDCs retract if the associated BCRs do not find Ag [<xref ref-type="bibr" rid="pcbi.1006408.ref026">26</xref>], we assume that the BCR has a characteristic time to find the Ag (see <xref ref-type="sec" rid="sec014">Methods</xref>). If it does not bind to Ag during that time, no Ag is captured (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1ci and 1cii</xref>). Once one of the arms of the BCR binds to Ag, an Ag molecule may be pulled away by force[<xref ref-type="bibr" rid="pcbi.1006408.ref027">27</xref>]. At this stage, there is a tug-of-war over the Ag between the BCR and the IC (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1ciii</xref>). Characteristically, when the binding energy between the BCR and the Ag is much larger than the binding energy between the Ag and the virus/Fc receptor/FDC membrane (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1</xref>), the Ag will be captured by the BCR. We denote the potential interaction energy required to extract the Ag by <italic>E</italic><sub><italic>Ag</italic>−<italic>mem</italic></sub>, and the interaction energy of the BCR/Ab and Ag by <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>. A successful Ag capture event occurs when the bond between the Ag and the membrane ruptures before the bond between the BCR and the Ag (see <xref ref-type="sec" rid="sec014">Methods</xref>).</p>
<p>When the off-rate of the BCR arm from the Ag is smaller or of the order of the effective on-rate (<italic>qN</italic><sub><italic>Ag</italic></sub>), and if one arm is attached initially (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1cii</xref>), the second BCR arm can bind to another Ag molecule if one is available. Thus, a pulling attempt can have three possible outcomes, with zero, one or two Ag molecules captured (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1d</xref>), depending on the binding affinity and the number of available and accessible Ag molecules <italic>N</italic><sub><italic>Ag</italic></sub>.</p>
</sec>
<sec id="sec006">
<title>Simplified model of GC reaction</title>
<p>In the first days following infection or immunization, <italic>M</italic> different clones (unique BCRs) of activated B cells proliferate with little competition, creating a pool of cells on which AM operates[<xref ref-type="bibr" rid="pcbi.1006408.ref028">28</xref>]. Few or no mutations are introduced to the BCR sequence at this early stage. We use a simple birth/death process to describe this initial growth stage.</p>
<p>B cells then start to mutate, and whether or not a B cell is subsequently positively selected depends on its ability to internalize Ag and compete with other B cells for survival signals by interacting with TfhCs. TfhCs have an important role in regulating the duration of the cell cycle in B cells during AM [<xref ref-type="bibr" rid="pcbi.1006408.ref017">17</xref>,<xref ref-type="bibr" rid="pcbi.1006408.ref018">18</xref>]. Following a TfhC signal, B cells divide (and mutate) multiple (4–6) times before going back for another round of selection [<xref ref-type="bibr" rid="pcbi.1006408.ref029">29</xref>–<xref ref-type="bibr" rid="pcbi.1006408.ref031">31</xref>].</p>
<p>Most theoretical models enforce selection by eliminating cells with low affinity BCR [<xref ref-type="bibr" rid="pcbi.1006408.ref023">23</xref>,<xref ref-type="bibr" rid="pcbi.1006408.ref024">24</xref>]. It has been shown [<xref ref-type="bibr" rid="pcbi.1006408.ref017">17</xref>] that TfhCs control the rate at which B cells go through the cell cycle. B cells that receive strong proliferation signal from the TfhCs divide multiple times in the dark zone before going back to the light zone. We model this behavior by using a birth-rate for B cells which is proportional to the amount of captured Ag.</p>
<p>The proliferation rate of B cells is a function of the number of captured Ag molecules, further modulated through competition for TfhCs. Indeed, it was shown [<xref ref-type="bibr" rid="pcbi.1006408.ref032">32</xref>], that TfhCs preferentially interact with B cells that have captured more Ag, presumably giving them a stronger proliferation signal. To mimic this competition we assume the birthrate of B cell <italic>i</italic> to be:
<disp-formula id="pcbi.1006408.e001">
<alternatives>
<graphic id="pcbi.1006408.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>〈</mml:mo><mml:mi>A</mml:mi><mml:mo>〉</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(1)</label>
</disp-formula>
where 〈<italic>A</italic>〉 is the average amount of Ag consumed by all B cells that captured <italic>at least</italic> 1 Ag (B cells that do not capture Ag have zero birth rate); <italic>β</italic><sub>0</sub> is the basal birthrate, and <italic>C</italic> is a measure of the availability of TfhC help. When <italic>C</italic>&gt;&gt;〈<italic>A</italic>〉, all B cells get the same amount of metabolic boost and divide at the same rate <italic>β</italic><sub>0</sub>. When <italic>C</italic>&lt;&lt;〈<italic>A</italic>〉 TfhC help is limiting and the cell birthrate is proportional to the amount of captured Ag. The GC has a limited capacity and grows during this competitive phase according to a stochastic logistic growth process. Thus, the selection process depends on the number of B cells in the system through the logistic death rate (<xref ref-type="sec" rid="sec014">Methods</xref> <xref ref-type="disp-formula" rid="pcbi.1006408.e012">Eq (6)</xref>). This logistic term accounts for the increased competition between B cells to receive a survival signal from TfhCs when the number of the latter is limiting. TfhCs are essential for GC maturation of B cells, and without them, AM of B cell cannot occur [<xref ref-type="bibr" rid="pcbi.1006408.ref033">33</xref>]. We assume here that the number of TfhCs is not so small as to stop the formation of the GC. Thus, at the limit where <italic>C</italic> goes to zero, our model does not corresponds to the absence of TfhCs in the GC. However, we do use the reduction of <italic>C</italic> to model increased B cells competition in a GC when the number of TfhCs is gradually reduced, as occurs during the first stages of HIV infection. For these reasons, we do not consider here the limit of <italic>C</italic>→0. In a more complete proliferation model <italic>C</italic> should depend on the total number of B cell in the GC and thus change with time. However, the qualitative behavior of our model would not change if the parameter <italic>C</italic> would have such explicit dependency on the GC size as upon HIV infection we expect Tfh levels to be smaller at all times than upon infection with other pathogens.</p>
</sec>
<sec id="sec007">
<title>Affinity change following BCR mutation</title>
<p>During AM, B cells mutate the BCR encoding gene using the AID enzyme. This results in changing cytosine to tyrosine on one DNA strand [<xref ref-type="bibr" rid="pcbi.1006408.ref034">34</xref>]. We modeled the effect of mutation as a change in the on-rate <italic>q</italic> or the interaction energy <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> upon cell division (see <xref ref-type="sec" rid="sec014">Methods</xref>). We convert the interaction energy to the off-rate by <inline-formula id="pcbi.1006408.e002"><alternatives><graphic id="pcbi.1006408.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e002" xlink:type="simple"/><mml:math display="inline" id="M2"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>A</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, and the affinity of the BCR is calculated as <italic>ω</italic> = <italic>q</italic>/<italic>r</italic><sub>0</sub>. Our simplified model assumes that affinity improvements and reductions (through <italic>q</italic> or <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>) are equally likely following mutation and that all mutations change affinity. These choices are certainly not realistic, but making advantageous mutations rarer than deleterious ones, or making some of the mutations silent or lethal (as in reality) do not change the qualitative results.</p>
</sec>
<sec id="sec008">
<title>Highest affinity antibodies are generated at an optimal spike density</title>
<p>To explore the role of SD on AM, we calculated the affinity of the most dominant clone at the end of the GC reaction (GCR), which is day 16 of the competitive phase. The affinity of this clone will play an important role in the resulting humoral immune response. An important observation is that the affinity of the dominant clone varies non-monotonically with the SD (<italic>n</italic><sub><italic>Ag</italic></sub>). <xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref> demonstrates this finding for a TfhC level that was limiting across the range of <italic>n</italic><sub><italic>Ag</italic></sub> (SD) spanning 0.01 to 0.36. There is also a pronounced asymmetry in the variation of affinity with <italic>n</italic><sub><italic>Ag</italic></sub>. As <italic>n</italic><sub><italic>Ag</italic></sub> increases from very small values, there is a sharp rise in affinity, while its drop for larger <italic>n</italic><sub><italic>Ag</italic></sub> is gradual. The number of B cells in the GC is not reduced when SD is high. Since B cells have to capture at least 1 Ag molecule in order to attempt proliferation, the average proliferation rate increases with SD.</p>
<fig id="pcbi.1006408.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Affinity maturation (AM) in a germinal center (GC).</title>
<p>Simulations of the GC reaction starting with 20 different B cell clones. During AM, cells mutate their BCR upon division, changing only the BCR interaction energy with the Ag (<italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>) and thus the off-rate <italic>r</italic><sub>0</sub> of the BCR from the Ag. (<bold>a</bold>) The mean affinity (<italic>ω</italic> = <italic>q</italic>/<italic>r</italic><sub>0</sub>) of the dominant clone at day 16 of the GC reaction in the competitive phase, as a function of spike density <italic>n</italic><sub><italic>Ag</italic></sub>. (<bold>b</bold>) Mean number of Ag molecules captured by the dominant clone at day 16 as a function of the spike density. (<bold>c</bold>) The capture probability of Ag molecules by a single BCR (Eq (S10)) when the binding energy of the BCR is <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> = 1.5. The other parameters of the captures process are listed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>. (<bold>d</bold>) The probability of selecting the weaker affinity B cell (see text) during the competitive phase. This probability depends on the spike density (Eq (S11)). We sampled energies of B cell pairs from the population energy distribution (<xref ref-type="supplementary-material" rid="pcbi.1006408.s008">S5 Fig</xref>) obtained in the simulation results shown in (a), to estimate the probability of the lower affinity cell proliferating before a higher affinity one, at different times during the GCR. The relative mild variation in this figure are amplified in multiple rounds of selection.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.g002" xlink:type="simple"/>
</fig>
<p>These qualitative results are robust to variations in the other parameters in the model (<xref ref-type="supplementary-material" rid="pcbi.1006408.s004">S1 Fig</xref>), and for mutations resulting in changes in <italic>q</italic> (<xref ref-type="supplementary-material" rid="pcbi.1006408.s005">S2 Fig</xref>) or <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>). (The variation of affinity with SD is less pronounced when mutations change <italic>q</italic> for technical reasons described in <xref ref-type="supplementary-material" rid="pcbi.1006408.s005">S2 Fig</xref>.)</p>
<p>In the GC, memory and plasma B cells are produced throughout the GCR [<xref ref-type="bibr" rid="pcbi.1006408.ref012">12</xref>]. As a proxy for the affinities of memory and plasma B cells produced during the maturation process, we randomly selected 10% of the B cells at each intermediate time point. The resulting average, displayed in (<xref ref-type="supplementary-material" rid="pcbi.1006408.s006">S3 Fig</xref>) still exhibits a non-monotonous dependence on SD similar to that observed in <xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>.</p>
<p>The mechanistic reason underlying these results relates to the amount of antigen that is internalized by B cells as <italic>n</italic><sub><italic>Ag</italic></sub> changes (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2b</xref>). Upon increasing <italic>n</italic><sub><italic>Ag</italic></sub> from a small value, the amount of Ag internalized by B cells grows significantly as it becomes more probable to bind one or two Ag molecules (see <xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2c</xref>). However, once the SD is sufficiently high, most BCRs bind/internalize on average the same amount of Ag irrespectively of their affinity (if it is above a threshold value), and it is difficult to distinguish B cells based on the affinity of their receptor for the antigen. Competition between B cells to be positively selected is not severe in the latter regime, limiting the driving force to increase affinity by further mutations. Thus, the affinity of the antibodies produced begins to decline beyond an optimal SD. The gradual drop-off in affinity as <italic>n</italic><sub><italic>Ag</italic></sub> becomes too high, compared to the sharp decline when <italic>n</italic><sub><italic>Ag</italic></sub> becomes too low, is because the number of internalized antigens rises very sharply as <italic>n</italic><sub><italic>Ag</italic></sub> increases from a low value, but then slowly saturates to its maximum for sufficiently high SDs as depicted in <xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2b</xref>. In the limit of high <italic>n</italic><sub><italic>Ag</italic></sub>, there is a finite probability for the BCR to capture 1 or 2 Ag mols. At this limit, the probability to extract one Ag mol is given by <italic>r</italic>/(<italic>r</italic> + <italic>λ</italic>) and the probability to extract two Ag mols is <italic>λ</italic>/(<italic>r</italic> + <italic>λ</italic>), where <italic>λ</italic> is the off-rate of an Ag mol from the membrane when one arm of the BCR is bound and <italic>r</italic> is the rupture rate of the BCR from an Ag mol when one arm of the BCR is bound.</p>
<p>Our model suggests that clonal diversity also varies with SD. When SD is low, antigen is scarce and the selection forces will be fiercer. That could result in a more rapid loss of diversity. We estimate diversity by computing the fraction of the GC comprised of the dominant clone (<xref ref-type="supplementary-material" rid="pcbi.1006408.s005">S2b Fig</xref>, <xref ref-type="supplementary-material" rid="pcbi.1006408.s007">S4a Fig</xref>), which we denote by <italic>f</italic><sub><italic>d</italic></sub>. For very low SD a few dominant clones comprise most of the GC’s B cells at the end of the GCR (large <italic>f</italic><sub><italic>d</italic></sub>). This is because for low SD, selection during AM is dominated by the large competitive advantage, compared to most B cells, of a few B cells that internalize more antigen due to stochastic fluctuations. As the SD increases, a greater number of B cells can internalize antigen successfully and the GCR produces a more diverse clonal population.</p>
<p>The fraction of dominant clones has a large variability across different GC realizations. Indeed, it has been shown [<xref ref-type="bibr" rid="pcbi.1006408.ref031">31</xref>] that while some GCs appear to have been taken over by a single clone at day 16, others show high clonal diversity. This is the direct result of stochastic selection forces at play in the GC [<xref ref-type="bibr" rid="pcbi.1006408.ref035">35</xref>]. A similar behavior is observed in our GC model (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s007">S4 Fig</xref>). Here, the source of stochasticity is the random Ag capture process, as well as the stochastic proliferation and death of B cells.</p>
<p>While the fraction of the dominant clone mostly decreases with increasing SD, the higher affinity of the BCR at intermediate density contributes to a small increase in <italic>f</italic><sub><italic>d</italic></sub>. Thus, <italic>f</italic><sub><italic>d</italic></sub> is not monotonically decreasing with SD. Indeed, the improved selection at an intermediate density leads to greater loss of diversity in this range, which appears as a small bump in <italic>f</italic><sub><italic>d</italic></sub> (approximately between <italic>n</italic><sub><italic>Ag</italic></sub> = [0.1, 0.18], see inset <xref ref-type="supplementary-material" rid="pcbi.1006408.s007">S4 Fig</xref>). This effect is more pronounced when the overall diversity loss is slower as a result of a smaller death rate (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s004">S1 Fig</xref>).</p>
</sec>
<sec id="sec009">
<title>Selection forces act with the highest fidelity at an intermediate spike density</title>
<p>To understand how cell selection in AM is related to Ag density, we estimated the probability <italic>P</italic><sub>weaker aff selection</sub> that, in any given round of mutation and selection, a B cell with a lower affinity for the antigen gets selected and expands in favor of another B cell that has a higher affinity. A B cell with a higher affinity receptor is likely to internalize more antigen, be more successful at obtaining a survival signal from T helper cells and proliferate more. However, because Ag capture is probabilistic, and the birthrate relates to the amount of captured Ag, there is a chance that a B cell with lower affinity will be selected in favor of one that expresses a higher affinity receptor.</p>
<p>To empirically estimate <italic>p</italic><sub>weaker aff selection</sub>, we sampled B cell pairs from the affinity distribution computed in our simulations (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s008">S5 Fig</xref>). We detail how the probability is estimated in the methods section. Interestingly, we find that the probability changes with time, and depends on Ag density (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2d</xref>). Importantly, <italic>p</italic><sub>weaker aff selection</sub> is minimal at intermediate Ag density, at a value similar to the maximum for the BCR affinities. Thus, very high or low SDs lead to poor differentiation between higher and lower affinity B cells. Because the B cells with a higher affinity are most likely to be chosen to proliferate at an intermediate SD, selection is strongest for such SD, and thus highest affinity antibodies evolve.</p>
</sec>
<sec id="sec010">
<title>Cooperative binding with two arms of the BCR leads to optimal affinity increase at intermediate densities</title>
<p>To further elucidate the origin of the maximum in antibody affinity at an intermediate SD, we studied the time evolution of the mean affinity of the B cell population. We aimed to find the dependency of the optimal density on the rates of different processes in our model, rather than attempt to recapitulate our simulation results. Assuming that the time <italic>τ</italic> to find the first Ag molecule before retracting the B cell protrusion is very long and that each B cell has only a single BCR, we find a mean-field equation (see SI) for the evolution of the mean on-rate <inline-formula id="pcbi.1006408.e003"><alternatives><graphic id="pcbi.1006408.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e003" xlink:type="simple"/><mml:math display="inline" id="M3"><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula>
<disp-formula id="pcbi.1006408.e004">
<alternatives>
<graphic id="pcbi.1006408.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e004" xlink:type="simple"/>
<mml:math display="block" id="M4">
<mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>cov</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>q</mml:mi><mml:mo>,</mml:mo><mml:mi>A</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mo>〈</mml:mo><mml:mi>A</mml:mi><mml:mo>〉</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(2)</label>
</disp-formula>
where 〈<italic>A</italic>〉 is the average amount of captured Ag by the B cell population (here 〈<italic>A</italic>〉 is between 0 and 2), cov(<italic>q</italic>, <italic>A</italic>) is the covariance between the number of captured Ag molecules <italic>A</italic> and <italic>q</italic>, <italic>C</italic><sub>1</sub> is the parameter that corresponds to TfhC availability parameter and <italic>τ</italic><sub>0</sub> ∝ (<italic>β</italic><sub>0</sub>−<italic>μ</italic><sub>0</sub>)<sup>-1</sup> is the time scale of the process. We recall Fisher’s fundamental theorem of natural selection stating that “The rate of increase in fitness of any organism at any time is equal to its genetic variance in fitness at that time” [<xref ref-type="bibr" rid="pcbi.1006408.ref036">36</xref>]. <xref ref-type="disp-formula" rid="pcbi.1006408.e004">Eq (2)</xref> is a generalization of Fisher’s fundamental theorem and is also reminiscent of Price’s equation [<xref ref-type="bibr" rid="pcbi.1006408.ref037">37</xref>] if we consider <italic>q</italic> to be a <italic>trait</italic> of the population. We further find that the variance <italic>σ</italic><sup>2</sup> of the on-rate distribution evolves as
<disp-formula id="pcbi.1006408.e005">
<alternatives>
<graphic id="pcbi.1006408.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e005" xlink:type="simple"/>
<mml:math display="block" id="M5">
<mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>cov</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>q</mml:mi><mml:mo>−</mml:mo><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>〈</mml:mo><mml:mi>A</mml:mi><mml:mo>〉</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mi>D</mml:mi><mml:mo>.</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(3)</label>
</disp-formula></p>
<p>Solving Eqs (<xref ref-type="disp-formula" rid="pcbi.1006408.e004">2</xref>) and (<xref ref-type="disp-formula" rid="pcbi.1006408.e005">3</xref>) numerically (<xref ref-type="supplementary-material" rid="pcbi.1006408.s009">S6 Fig</xref>), we find that <inline-formula id="pcbi.1006408.e006"><alternatives><graphic id="pcbi.1006408.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e006" xlink:type="simple"/><mml:math display="inline" id="M6"><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> exhibits the same non-monotonic behavior as in our simulation results <xref ref-type="supplementary-material" rid="pcbi.1006408.s005">S2a Fig</xref>. When TfhC level is scarce (small <italic>C</italic><sub>1</sub>), the affinity increases faster due to the increased competition between B cells (<xref ref-type="supplementary-material" rid="pcbi.1006408.s009">S6 Fig</xref>). The position of the optimal density changes with time (<xref ref-type="supplementary-material" rid="pcbi.1006408.s009">S6 Fig</xref>) towards smaller Ag densities. For a given on-rate distribution (fixed mean and variance), the rate of increase in affinity is maximal at density <italic>n</italic>* given by
<disp-formula id="pcbi.1006408.e007">
<alternatives>
<graphic id="pcbi.1006408.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e007" xlink:type="simple"/>
<mml:math display="block" id="M7">
<mml:mrow><mml:msup><mml:mi>n</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mo>+</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mi>ξ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mi>ξ</mml:mi></mml:mrow></mml:mfrac><mml:msqrt><mml:mrow><mml:mfrac><mml:mrow><mml:mi>λ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mo>+</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>r</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>λ</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msqrt><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(4)</label>
</disp-formula>
where <italic>λ</italic> and <italic>ξ</italic> are the off-rates of the Ag from the IC when one or two arms of the BCR are bound, respectively. <italic>r</italic> and <italic>k</italic> are the BCR arm rupture rate from the Ag when one or two arms of the BCR are bound to Ag, respectively (see SI).</p>
<p>When the interaction energy of the Ab and the Ag is equal to that of the Ag with the IC (<italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> = <italic>E</italic><sub><italic>Ag</italic>−<italic>mem</italic></sub>), the optimal density is
<disp-formula id="pcbi.1006408.e008">
<alternatives>
<graphic id="pcbi.1006408.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e008" xlink:type="simple"/>
<mml:math display="block" id="M8">
<mml:mrow><mml:msup><mml:mi>n</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mn>4</mml:mn><mml:mfrac><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>β</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mi>F</mml:mi></mml:mrow></mml:msup><mml:msqrt><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>C</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:msqrt><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(5)</label>
</disp-formula>
where <italic>λ</italic><sub>0</sub> is the disassociation rate of the Ag from the IC. Thus, at the optimal selection density, the characteristic effective on-rate (<inline-formula id="pcbi.1006408.e009"><alternatives><graphic id="pcbi.1006408.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e009" xlink:type="simple"/><mml:math display="inline" id="M9"><mml:mrow><mml:msup><mml:mi>n</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula>) is equal to <italic>λ</italic><sub>0</sub>. At this density, B cells spilt into different populations, each capturing a different amount of Ag.</p>
<p>Interestingly, for very large values of <italic>q</italic>, the number of captured Ag molecules <italic>A</italic> is independent of <italic>q</italic> as the covariance between them goes to zero (see SI). In this limit, it is impossible to differentiate between B cells affinities and the mean affinity stops increasing, reaching an asymptotic value. Similarly, the variance of the distribution reaches an asymptotic value.</p>
<p>Finally, we speculated whether a scenario where the BCR has one arm (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s010">S7 Fig</xref>) would still show the non-monotonic dependence on Ag density. We estimated the time evolution of <inline-formula id="pcbi.1006408.e010"><alternatives><graphic id="pcbi.1006408.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e010" xlink:type="simple"/><mml:math display="inline" id="M10"><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> for a hypothetical BCR with one arm (see SI and <xref ref-type="supplementary-material" rid="pcbi.1006408.s010">S7 Fig</xref>). Interestingly, when the time <italic>τ</italic> to find the first Ag molecule is of the same order as the effective on-rate (basal on-rate multiplied by the density), the mean affinity has a maximum at intermediate densities (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s010">S7 Fig</xref>). However, <italic>τ</italic> is likely much larger than the on-rate, in which case the affinity is monotonically decreasing as a function of the Ag density (see <xref ref-type="supplementary-material" rid="pcbi.1006408.s010">S7 Fig</xref>). We conclude that the optimal SD observed in our simulations is a direct result of the <italic>cooperativity</italic> between the two arms of the BCR because the analytical model shows that an optimal SD emerges only when the BCR has two arms. The cooperativity allows a second arm to search and bind an Ag molecule while the first is bound to another Ag molecule on the surface of the IC.</p>
</sec>
<sec id="sec011">
<title>Ag depletion improves AM at high SD</title>
<p>During AM, Ag is depleted from IC as it is being consumed by the B cells. As shown in the previous sections, AM depends on the ability of the GCR to differentiate bewteen B cells of different affinities. Optimal selection is achieved when only B cells with the highest affinity are likely to capture 2 Ag molecules (see <xref ref-type="disp-formula" rid="pcbi.1006408.e008">Eq (5)</xref>). Depletion of Ag from FDCs during AM will result in fewer immune complexes encountered by the BCRs. It will not change the local SD on the virus. Rather, it will reduce the first encounter probability of Ag molecules by a BCR (See <xref ref-type="disp-formula" rid="pcbi.1006408.e014">Eq (7)</xref>). To study how the competative forces may be modulated in time, we studied a hypothetical scenario where SD exponentially decays during AM (<inline-formula id="pcbi.1006408.e011"><alternatives><graphic id="pcbi.1006408.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e011" xlink:type="simple"/><mml:math display="inline" id="M11"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>t</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>). Interestingly, when the SD decays, selection improves when the initial SD is high (<xref ref-type="supplementary-material" rid="pcbi.1006408.s011">S8 Fig</xref>). As a result, the affinity at day 16 of the GCR is higher compared to the fixed SD scenario (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>). At high SD, as the affinity of the B cell population improves, decreasing SD allows the GCR to remain at close to the optimal differention point. However, decreasing Ag density harms the development of GCs for which the initial SD is low. Since B cell have to capture at least one Ag mol to proliferate, most GCs do not succeed in reaching day 16 (<xref ref-type="supplementary-material" rid="pcbi.1006408.s011">S8 Fig</xref>) in this limit.</p>
</sec>
<sec id="sec012">
<title>Depleted TfhC numbers during HIV infection affects AM in a way that favors a low virus SD</title>
<p>HIV dominantly infects CD4 T cells and significantly reduces their number immediately following infection during a time when the first antibody responses are developing in the host [<xref ref-type="bibr" rid="pcbi.1006408.ref038">38</xref>]. We therefore explored the effects of making TfhC activity even more limiting (than what is usual). To do so, we changed the parameter <italic>C</italic> (<xref ref-type="disp-formula" rid="pcbi.1006408.e001">Eq (1)</xref>), which represents the availability of TfhCs during AM. Again, we use the affinity of the dominant clone at the end of the GCR as a metric of the affinity of antibodies generated. Previously (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>) we found that for high SDs, antibody affinity was lower than optimal. This was because, for sufficiently high SD, most BCRs internalized one or two antigens and so competition between B cells was restricted. But, when the level of TfhC (<italic>C</italic>) is even more limiting, even for high SDs, small differences between B cells with regard to the amount of internalized antigens are amplified by the intense competition between B cells for interacting with, and receiving a survival signal from TfhCs (<xref ref-type="fig" rid="pcbi.1006408.g003">Fig 3a</xref>, <xref ref-type="supplementary-material" rid="pcbi.1006408.s012">S9 Fig</xref>). Thus, if the SD is high, more potent antibodies are generated as TfhC levels decline. However, when the SD is low, decreasing <italic>C</italic> does not alter the affinity of the resulting antibodies significantly. Consistent with this result, the probability of selecting the lower affinity B cell decreases as <italic>C</italic> decreases (see <xref ref-type="fig" rid="pcbi.1006408.g003">Fig 3b</xref>). This is because selection is a stronger force when there are fewer TfhCs. In agreement with our result in <xref ref-type="fig" rid="pcbi.1006408.g003">Fig 3a</xref>, this enhancement in selection forces is more pronounced at intermediate and high SDs compared to low SDs. Thus, as TfhC levels are smaller, high affinity antibodies can be generated more readily for high SDs. Thus, perhaps, HIV, which is the only virus that principally targets T helper cells and depletes their numbers, evolved a low SD to prevent strong antibody responses from developing during the early stages of infection when T helper cell levels rapidly decline. (Note that Human T cell Leukemia viruses also infect T cells, but they do not result in a sharp decline in T helper cell numbers [<xref ref-type="bibr" rid="pcbi.1006408.ref039">39</xref>]. Their effect on the number and functioning of TfhCs is still unclear [<xref ref-type="bibr" rid="pcbi.1006408.ref040">40</xref>]).</p>
<fig id="pcbi.1006408.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Effect of T helper cell level and spike density on affinity maturation.</title>
<p>(<bold>a</bold>) The average affinity of the dominant clone in a GC increases for viruses exhibiting a high spike density as Tfh levels (<italic>C</italic>) decline. Different curves correspond to different values of spike density (<italic>n</italic><sub><italic>Ag</italic></sub>). <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> changes upon mutation in these simulations. (<bold>b</bold>) The probability of selecting the wrong B cell (see text) is shown for different values of <italic>C</italic>. The probability shown is a time average over all GCR days.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.g003" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec013" sec-type="conclusions">
<title>Discussion</title>
<p>Proteins that comprise the spikes on the surface of viruses bind to receptors on host cells to propagate infection. A high SD increases the probability of encounters with the host cell’s receptor, thus enhancing infectivity [<xref ref-type="bibr" rid="pcbi.1006408.ref041">41</xref>]. At the same time, the viral spike is the target of immune attack by antibodies [<xref ref-type="bibr" rid="pcbi.1006408.ref042">42</xref>] and a high SD may make the virus more susceptible to neutralization. For example, HIV’s low SD can inhibit effective neutralization [<xref ref-type="bibr" rid="pcbi.1006408.ref003">3</xref>]. The average inter-spike distance for HIV is about 23nm, while the average distance between the arms of the Ab is 15nm. Thus, the two Ab arms are unlikely to bind simultaneously to two Ag molecules, which would decrease avidity [<xref ref-type="bibr" rid="pcbi.1006408.ref003">3</xref>]. In some viruses like influenza, however, hypervariable features near the head of the spike have high immunogenicity, and a high SD can serve to protect the virus from antibodies that could target more conserved epitopes in the stem of the virus [<xref ref-type="bibr" rid="pcbi.1006408.ref004">4</xref>]. Thus, there appear to be evolutionary forces that favor both a high and low virus SD. Yet, most viruses have very high SD, and HIV appears to be unique in that its SD is about two orders of magnitude lower (see <xref ref-type="table" rid="pcbi.1006408.t001">Table 1</xref>).</p>
<p>In order to shed light on the evolutionary forces that may have led to the evolution of a low SD for HIV, we studied a simplified computational model of AM. We found that the affinity of Abs produced by GC reactions is maximal for an intermediate SD (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>). For very low SD, most B cells internalize a single antigen molecule by binding via a single arm of the BCR or internalize no antigen at all. The occasional B cell that internalizes Ag by chance quickly evolves to become the dominant clone during AM. Thus, for very low SD, fluctuations prevent the system from being in the strong selection regime, thus resulting in lower affinity antibodies. For a high SD, BCRs on B cells are very likely to internalize one or two Ags, and so soon after AM ensues, most B cells internalize quite a bit of antigen. Therefore, there is reduced competition between B cells for obtaining a survival signal from TfhCs, and thus a low driving force to evolve higher affinity BCRs. An intermediate SD results in strong selection forces, and the highest affinity antibodies.</p>
<p>The basis for the optimal affinity at intermediate SD being related to the ability to differentiate between B cells with different affinities during the GC reaction is made clear by another aspect of our results. We show that the non-monotonic dependence of antibody affinity with SD is directly related to the binding cooperativity between the two arms of the BCR. Indeed, for a hypothetical single arm BCR, the affinity of the resulting Abs monotonically decreases with SD (<xref ref-type="supplementary-material" rid="pcbi.1006408.s010">S7 Fig</xref>). For normal BCRs with two arms, at the optimal density, the second arm serves to split the B cell population into those who manage to capture the additional Ag molecule while the first arm is still bound, and those who do not. Thus, resulting in strong selection for the B cells that internalize two antigens per BCR.</p>
<p>We thus hypothesize that having two arms may be beneficial for optimal B cell selection in the GC. Obviously, the two arms allow Abs to bind Ag with high avidity. However, the two arms also allow for a more precise differentiation between B cells. B cells usually capture Ag using BCR clusters [<xref ref-type="bibr" rid="pcbi.1006408.ref026">26</xref>] that can function as a “multiple arms” BCR for the purpose of differentiation. However, perhaps it is most beneficial for the BCR to have two arms (in the context of GC selection) when Ag density is very low.</p>
<p>The probability that a lower affinity B cell is stochastically selected to proliferate in favor of a higher affinity B cell is minimal for the intermediate densities. In other words, the ability of the GC reaction to produce highest affinity Abs at an intermediate SD is because this is the regime where selection effects are strongest. So, viruses could have evolved either a low or high SD to reduce the efficacy of antibodies directed against them. The results in <xref ref-type="fig" rid="pcbi.1006408.g004">Fig 4</xref> suggest that evolving a low SD would be especially advantageous from this perspective. Furthermore, such a strategy reduces the avidity of antibodies, further inhibiting neutralization [<xref ref-type="bibr" rid="pcbi.1006408.ref043">43</xref>]. However, most viruses have evolved a high SD (<xref ref-type="table" rid="pcbi.1006408.t001">Table 1</xref>). Our results suggest that this may be because the evolutionary driving forces of increasing infectivity and shielding conserved epitopes by maintaining a high packing density may be dominant. A very high SD (past the optimal density for AM) can lower antibody affinity somewhat (<xref ref-type="fig" rid="pcbi.1006408.g004">Fig 4</xref>) while favoring these two selection forces.</p>
<fig id="pcbi.1006408.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.g004</object-id>
<label>Fig 4</label>
<caption>
<title>The immune pressure on a virus may determine its spike density.</title>
<p>The distribution of viruses species according to their spike density (see <xref ref-type="table" rid="pcbi.1006408.t001">Table 1</xref>). We illustrate the immune pressure created by Ab affinity (orange), which is non-monotonous with density. The infectivity of a virus increases with its spike density (green).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.g004" xlink:type="simple"/>
</fig>
<p>Why has HIV evolved SD that is roughly two orders of magnitude smaller than that observed for most viruses? HIV is unique in that it principally infects T helper cells and reduces their numbers significantly during the early stages of infection. We suggest that T helper cell depletion during HIV infection results in increased competition between B cells during AM. When T helper cells are limiting to the normal extent, once the SD is higher than the optimal value, selection forces are weaker. But, if T helper cells are significantly depleted, selection forces remain strong at high SDs, resulting in high affinity antibodies. As <xref ref-type="fig" rid="pcbi.1006408.g003">Fig 3b</xref> shows, depletion of TfhCs results in a lower probability of low-affinity B cells stochastically proliferating in favor of higher affinity B cells. However, our results show that, for low SDs, Ab affinity hardly increases upon depletion of TfhCs. This may be the reason that HIV, which is the only known virus that principally infects T helper cells and sharply depletes their numbers during early stages of infection, is the rare virus that has evolved a low SD. The low SD may aid HIV to avoid effective antibody responses in the early stages of infection in a way that would not be possible if it had a high SD. We note also that a low SD can decrease the ability to form diverse clonal lineages during the GC reaction, thus inhibiting AM from deeply exploring the antigenic space upon infection [<xref ref-type="bibr" rid="pcbi.1006408.ref044">44</xref>]. Because it is a chronic infection and replicates fast, the reduced infectivity of a low SD may be alleviated.</p>
<p>The Measles virus also infects T helper cells; could result in their depletion [<xref ref-type="bibr" rid="pcbi.1006408.ref045">45</xref>] and causes transient immunosuppression [<xref ref-type="bibr" rid="pcbi.1006408.ref046">46</xref>]. Unlike HIV, Measles causes acute disease and is rapidly cleared from the body. Notably, Measles has many spikes on its surface [<xref ref-type="bibr" rid="pcbi.1006408.ref043">43</xref>]. We hypothesize that its rapid mode of propagation resulted in its choice to have high infectivity, producing many virions in the short period during which the patient is infectious. An HIV carrier, on the other hand, is infectious for an extended period. Thus, the virus has to hide for much longer from the immune system and having a low spike density would allow it to do so. Finally, it seems that affinity maturation and antibody response is not the main way by which Measles is cleared. Rather, it induces a T cell response that is dominant in the first two weeks [<xref ref-type="bibr" rid="pcbi.1006408.ref047">47</xref>]. Only at a much later times (many weeks) affinity maturation starts to produce antibodies against Measles’s RNA and proteins [<xref ref-type="bibr" rid="pcbi.1006408.ref047">47</xref>]. Another virus that infects T helper cells is HTLV-1. Contrary to HIV, HTLV-1 infection does not appear to result in a sharp decline of the T-cell population but it may impair the function of TfhCs [<xref ref-type="bibr" rid="pcbi.1006408.ref048">48</xref>]. Our model would suggest that this effect should promote the evolution of a low SD. Another feature of HTLV suggests that a high SD for improving infectivity may be ameliorated; HTLV-1 predominantly infects new cells via cell-to-cell contact [<xref ref-type="bibr" rid="pcbi.1006408.ref049">49</xref>][<xref ref-type="bibr" rid="pcbi.1006408.ref050">50</xref>]. It seems that during cell-to-cell transfer, at the intersection between the two cells, the local density of env is high [<xref ref-type="bibr" rid="pcbi.1006408.ref049">49</xref>]. However, while we could not find precise quantification of their number on the free virions (which is the key variable during affinity maturation), spikes appear sparse on their surface when imaged with cryo-EM [<xref ref-type="bibr" rid="pcbi.1006408.ref051">51</xref>]. Given this paucity of quantitative data, at this stage, it is not clear how our hypothesis relating spike density and T cell number to the competitive force in the GC should be applied to HTLV-1.</p>
<p>The impact of SD on HIV and SIV propagation has been studied experimentally. A deletion in the tail of gp41 (part of the Env spike protein) has been suggested to increase the number of spikes [<xref ref-type="bibr" rid="pcbi.1006408.ref041">41</xref>] and their mobility [<xref ref-type="bibr" rid="pcbi.1006408.ref052">52</xref>]. These mutated virions have better infectivity in cell culture [<xref ref-type="bibr" rid="pcbi.1006408.ref053">53</xref>]. Surprisingly, the deletion is rarely seen in vivo and when macaques are infected with a short tail SIV mutant, the mutant reverts back to the long tail virus [<xref ref-type="bibr" rid="pcbi.1006408.ref053">53</xref>–<xref ref-type="bibr" rid="pcbi.1006408.ref055">55</xref>]. These results may suggest an evolutionary driving force, in the face of an immune response, to reduce SD in HIV.</p>
<p>Our results are reminiscent of the pioneering discovery by Herman Eisen showing that affinity increase upon AM was smaller for a very high Ag dose, suggesting that too high Ag concentration decreases competition in the GC. There is also experimental evidence that intermediate levels of antigen density lead to the highest Ab titers [<xref ref-type="bibr" rid="pcbi.1006408.ref056">56</xref>], related to optimal BCR activation. In this case, Ag molecules can mediate the formation of a BCR cluster when the density is sufficiently high, while for very high density, Ag sequesters the BCR molecules and the number of fully formed clusters is reduced.</p>
<p>Our results are relevant to vaccine design. It is possible to design liposomal nanoparticles that display varying density of Ag [<xref ref-type="bibr" rid="pcbi.1006408.ref011">11</xref>,<xref ref-type="bibr" rid="pcbi.1006408.ref057">57</xref>,<xref ref-type="bibr" rid="pcbi.1006408.ref058">58</xref>]. We have shown here that more is not necessarily better. We suggest that a precise design of the density of Ag can impact B cell selection in the GC, and as a result on the Ab affinity of the memory and plasma cells that are the product of vaccination. Thus, our results may guide the design of vaccination vectors that could optimize immune responses in the lymph node follicle.</p>
<p>Our arguments regarding the evolutionary driving forces that have led to HIV being unique in exhibiting an extraordinarily low SD may be difficult to examine experimentally (as is the case for most problems in evolutionary biology that are not contrived laboratory curiosities). However, by depleting TfhCs in mice to different degrees, the veracity of the underlying mechanism could be tested.</p>
</sec>
<sec id="sec014" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec015">
<title>The growth of the GC</title>
<p>To account for the limited capacity of a GC during the competitive phase, we employed a variant of the stochastic logistic growth process [<xref ref-type="bibr" rid="pcbi.1006408.ref059">59</xref>], in which the death rate increases with the overall population size, from a basal rate of <italic>μ</italic><sub>0</sub>, as
<disp-formula id="pcbi.1006408.e012">
<alternatives>
<graphic id="pcbi.1006408.e012g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e012" xlink:type="simple"/>
<mml:math display="block" id="M12">
<mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mtext mathvariant="bold">n</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow><mml:mi>N</mml:mi></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(6)</label>
</disp-formula></p>
<p>Here, <italic>N</italic> is the population capacity taken to be 200; <bold>n</bold> = (<italic>n</italic><sub>1</sub>, <italic>n</italic><sub>2</sub>,…,<italic>n</italic><sub><italic>M</italic></sub>) is the vector of cell numbers <italic>n</italic><sub><italic>i</italic></sub> for the <italic>M</italic> clones such that <inline-formula id="pcbi.1006408.e013"><alternatives><graphic id="pcbi.1006408.e013g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e013" xlink:type="simple"/><mml:math display="inline" id="M13"><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></alternatives></inline-formula> is the total number of B cells in the GC. The competitive phase lasts about 16 days in mice [<xref ref-type="bibr" rid="pcbi.1006408.ref031">31</xref>]. The total number of cells in the GC grows gradually until reaching the capacity <italic>N</italic>, where it remains approximately fixed.</p>
</sec>
<sec id="sec016">
<title>Ag encounter and binding by the BCR</title>
<p>We assume here that an arm of a BCR at the tip of a B cell protrusion has a characteristic time <italic>τ</italic> to find an Ag molecule, after which the protrusion retracts empty. The probability that an arm of a BCR at the tip of a B cell protrusion finds Ag before time <italic>τ</italic> is
<disp-formula id="pcbi.1006408.e014">
<alternatives>
<graphic id="pcbi.1006408.e014g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e014" xlink:type="simple"/>
<mml:math display="block" id="M14">
<mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo>:</mml:mo><mml:mo>=</mml:mo><mml:mtext>Probability</mml:mtext><mml:mspace width="1pt"/><mml:mo>{</mml:mo><mml:mtext>One</mml:mtext><mml:mspace width="1pt"/><mml:mtext>arm</mml:mtext><mml:mspace width="1pt"/><mml:mtext>binding</mml:mtext><mml:mspace width="1pt"/><mml:mtext>before</mml:mtext><mml:mspace width="1pt"/><mml:mtext>time</mml:mtext><mml:mspace width="1pt"/><mml:mi>τ</mml:mi><mml:mo>}</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mi>τ</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(7)</label>
</disp-formula>
where <inline-formula id="pcbi.1006408.e015"><alternatives><graphic id="pcbi.1006408.e015g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e015" xlink:type="simple"/><mml:math display="inline" id="M15"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>q</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> is the on-rate for the BCR to find an Ag molecule given that there are <italic>N</italic><sub><italic>Ag</italic></sub> of them in its scanning radius, and the sequence-dependent on-rate with which a particular BCR binds to Ag is <italic>q</italic>. This leads to
<disp-formula id="pcbi.1006408.e016">
<alternatives>
<graphic id="pcbi.1006408.e016g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e016" xlink:type="simple"/>
<mml:math display="block" id="M16">
<mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:msub><mml:mi>p</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mi>τ</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mi>τ</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable>
</mml:math>
</alternatives>
<label>(8)</label>
</disp-formula>
where <italic>p</italic><sub>0</sub> is the probability that no Ag is encountered, while <italic>p</italic><sub>1</sub> is the probability that one of the arms encounters an Ag molecule in this time period.</p>
</sec>
<sec id="sec017">
<title>Ag internalization</title>
<p>In order to capture the Ag, the BCR attached to a protrusion of the B cell applies a pulling force that works against the interactions of the BCR with Ag, and that between the Ag and the virus/Fc receptor/FDC membrane (see <xref ref-type="fig" rid="pcbi.1006408.g001">Fig 1</xref>). We denote the potential interaction energy required to extract the Ag by <italic>E</italic><sub><italic>Ag</italic>−<italic>mem</italic></sub>, and the interaction energy of the BCR/Ab and Ag by <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>.</p>
<p>The characteristic rupture time depends on the force applied by the B cell [<xref ref-type="bibr" rid="pcbi.1006408.ref060">60</xref>]. The force <italic>F</italic> does work <italic>x</italic><sub><italic>b</italic></sub><italic>F</italic> on the bond, reducing its free energy and increasing the rupture rate to <inline-formula id="pcbi.1006408.e017"><alternatives><graphic id="pcbi.1006408.e017g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e017" xlink:type="simple"/><mml:math display="inline" id="M17"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>F</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>β</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mi>F</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, where <italic>r</italic><sub>0</sub> is the characteristic rate for bond disassociation when no force is present, <italic>x</italic><sub><italic>b</italic></sub> is the distance at which the bond ruptures, and <italic>β</italic> = <italic>k</italic><sub><italic>B</italic></sub><italic>T</italic>. The intrinsic rupture rate with no force is estimated by Kramer’s escape from a potential barrier as
<disp-formula id="pcbi.1006408.e018">
<alternatives>
<graphic id="pcbi.1006408.e018g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e018" xlink:type="simple"/>
<mml:math display="block" id="M18">
<mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mi>K</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>A</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(9)</label>
</disp-formula>
where <italic>K</italic> is a coefficient that depends on the shape of the interaction potential [<xref ref-type="bibr" rid="pcbi.1006408.ref061">61</xref>]. We take <italic>K</italic> = 1, and note that in writing <xref ref-type="disp-formula" rid="pcbi.1006408.e018">Eq (9)</xref> we have assumed that the activation barrier to form the bond is much smaller than the energy gained upon binding (<italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>). <italic>F</italic> is typically of the order of a few pico-Newtons [<xref ref-type="bibr" rid="pcbi.1006408.ref027">27</xref>]. We assume that each B cell has 100 BCRs but the qualitative behavior of our results does not depend on the number of BCRs. As each BCR can extract 0/1/2 Ag molecules, a B cell can extract between 0 and 200 Ag molecules.</p>
</sec>
<sec id="sec018">
<title>Affinity change following BCR mutation</title>
<p>We modeled the effect of mutation as a change in the on-rate <italic>q</italic> or the interaction energy <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> upon cell division, with one daughter retaining the parent affinity, while for the other daughter:
<disp-formula id="pcbi.1006408.e019">
<alternatives>
<graphic id="pcbi.1006408.e019g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e019" xlink:type="simple"/>
<mml:math display="block" id="M19">
<mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>-</mml:mo><mml:mi>A</mml:mi><mml:mi>b</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>A</mml:mi><mml:mi>b</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mtext>N</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mi>D</mml:mi></mml:mrow></mml:msqrt><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mtext>N</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mi>D</mml:mi></mml:mrow></mml:msqrt><mml:mo stretchy="false">)</mml:mo></mml:mtd></mml:mtr></mml:mtable>
</mml:math>
</alternatives>
<label>(10)</label>
</disp-formula></p>
<p>Here, N is a normal distribution with zero mean and standard deviation of <inline-formula id="pcbi.1006408.e020"><alternatives><graphic id="pcbi.1006408.e020g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e020" xlink:type="simple"/><mml:math display="inline" id="M20"><mml:mrow><mml:msqrt><mml:mrow><mml:mn>2</mml:mn><mml:mi>D</mml:mi></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></inline-formula>, with <italic>D</italic> akin to an effective variability coefficient determining the magnitude of the change in <italic>q</italic> or <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>. Within this model, the energy, or <italic>q</italic>, can increase or decrease with equal probability at every division. We added a reflecting boundary condition at zero such that <italic>q</italic> is never negative. Since the off-rate scales as <inline-formula id="pcbi.1006408.e021"><alternatives><graphic id="pcbi.1006408.e021g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e021" xlink:type="simple"/><mml:math display="inline" id="M21"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>A</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>, the affinity of the BCR is calculated as <italic>ω</italic> = <italic>q</italic>/<italic>r</italic><sub>0</sub>.</p>
</sec>
<sec id="sec019">
<title>Simulation algorithm</title>
<p>To study the time evolution of the GC reaction, we performed Brownian dynamics simulations. At every time point B cells proliferate or die with a probability which is determined by the time step and the proliferation and death rates (<xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>). We choose the time step to be smaller than the average time for proliferation. The simulation proceeds according to the following algorithm:</p>
<list list-type="order">
<list-item><p>Initial seed of the GC with <italic>M</italic> clones.</p></list-item>
<list-item><p><bold>Growth phase</bold>. B cells proliferate and die without competition according to a stochastic birth-death process with rates <italic>β</italic><sub>0</sub>, <italic>μ</italic><sub>0</sub>. This phase lasts <italic>T</italic><sub><italic>growth</italic></sub> days. The values of these parameters is detailed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>.</p></list-item>
<list-item><p><bold>Competitive phase</bold>. B cells proliferate and die with competition according to a stochastic birth-death process with birth rate <inline-formula id="pcbi.1006408.e022"><alternatives><graphic id="pcbi.1006408.e022g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e022" xlink:type="simple"/><mml:math display="inline" id="M22"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mfrac><mml:mrow><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo>〈</mml:mo><mml:mi>A</mml:mi><mml:mo>〉</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula> (see <xref ref-type="disp-formula" rid="pcbi.1006408.e001">Eq (1)</xref>) and logistic death rate <inline-formula id="pcbi.1006408.e023"><alternatives><graphic id="pcbi.1006408.e023g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e023" xlink:type="simple"/><mml:math display="inline" id="M23"><mml:mrow><mml:mi>μ</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mtext mathvariant="bold">n</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow><mml:mi>N</mml:mi></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> (see <xref ref-type="disp-formula" rid="pcbi.1006408.e012">Eq (6)</xref>). This phase lasts <italic>T</italic><sub><italic>comp</italic></sub> days. The values of these parameters is detailed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>. In the stochastic simulation, at each time step:
<list list-type="alpha-lower">
<list-item><p>B cells attempt to capture Ag (see section “Ag encounter and binding by the BCR”, “Ag internalization”).</p></list-item>
<list-item><p>B cells divide with the rate given by <italic>β</italic><sub><italic>i</italic></sub> (see <xref ref-type="disp-formula" rid="pcbi.1006408.e001">Eq (1)</xref>). B cells have to capture at least 1 Ag molecule to attempt proliferation.</p></list-item>
<list-item><p>The progeny of a B cell mutates its BCR affinity (see section “Affinity change following BCR mutation”).</p></list-item>
<list-item><p>B cells die with a rate <italic>μ</italic>(<bold>n</bold>).</p></list-item>
</list></p></list-item>
</list>
<table-wrap id="pcbi.1006408.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1006408.t002</object-id>
<label>Table 2</label> <caption><title>Simulation parameters.</title></caption>
<alternatives>
<graphic id="pcbi.1006408.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Parameters used in the simulation</th>
<th align="left">Value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>M</italic>: number of initial clones:</td>
<td align="left">20</td>
</tr>
<tr>
<td align="left"><italic>μ</italic><sub>0</sub>: basal death rate</td>
<td align="left">1 day<sup>-1</sup></td>
</tr>
<tr>
<td align="left"><italic>β</italic><sub>0</sub>: basal birth rate</td>
<td align="left">1.5 day<sup>-1</sup></td>
</tr>
<tr>
<td align="left"><italic>N</italic>: germinal center capacity</td>
<td align="left">200</td>
</tr>
<tr>
<td align="left"><italic>D</italic>: variability coefficient</td>
<td align="left">0.05</td>
</tr>
<tr>
<td align="left"><italic>ω</italic><sub>0</sub>: initial affinity</td>
<td align="left">1.5</td>
</tr>
<tr>
<td align="left"><italic>T</italic><sub><italic>growth</italic></sub>: Growth phase</td>
<td align="left">4 days</td>
</tr>
<tr>
<td align="left"><italic>T</italic><sub><italic>comp</italic></sub>: competitive phase</td>
<td align="left">16 days</td>
</tr>
<tr>
<td align="left"><italic>F</italic>: Pulling force</td>
<td align="left">1 pN</td>
</tr>
<tr>
<td align="left"><italic>E</italic><sub><italic>Ag</italic>−<italic>mem</italic></sub>: interaction energy between the Ag and the immune complex on the FDC</td>
<td align="left">1k<sub>B</sub>T</td>
</tr>
<tr>
<td align="left"><italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub>: initial interaction energy between the Ag and the BCR. When mutating the bond energy this value change during the simulation.</td>
<td align="left">0.4k<sub>B</sub>T</td>
</tr>
<tr>
<td align="left"><italic>q</italic> (on-rate): initial activation rate for the encounter between the BCR and the Ag. When mutating the bond energy this value change during the simulation.</td>
<td align="left">0.5 t.u<sup>-1</sup></td>
</tr>
<tr>
<td align="left"><italic>x</italic><sub><italic>b</italic></sub>: the distance at which a bond breaks.</td>
<td align="left">1nm</td>
</tr>
<tr>
<td align="left">Number of BCR molecules per B cell</td>
<td align="left">100</td>
</tr>
<tr>
<td align="left"><italic>τ</italic>: the maximal search time of Ag by the BCR at the B cell protrusion in the immune synapse. After this time, the protrusion retracts with no Ag captured.</td>
<td align="left">1 t.u</td>
</tr>
<tr>
<td align="left"><italic>p</italic>: The probability that an Ag molecule will be in the searching radius of the BCR.</td>
<td align="left">0.09</td>
</tr>
<tr>
<td align="left"><italic>C</italic>: availability of T follicular help cells (TfhCs).</td>
<td align="left">75</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
</sec>
<sec id="sec020">
<title>Supporting information</title>
<supplementary-material id="pcbi.1006408.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s001" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>Spike densities of different viruses.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s002" xlink:type="simple">
<label>S2 Text</label>
<caption>
<title>This file provides a detailed explaination of <xref ref-type="supplementary-material" rid="pcbi.1006408.s004">S1 Fig</xref> showing that AM is optimal for intermediate spike density.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s003" xlink:type="simple">
<label>S3 Text</label>
<caption>
<title>Numerical methods.</title>
<p>The file contains the details of the computations.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s004" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s004" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Fraction of dominant clone, and the average affinity, for different simulation parameters.</title>
<p>(<bold>a-b</bold>) The fraction of the GC occupied by the dominant clone (a) and its mean affinity (b) at day 16, where <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> changes upon mutation while <italic>q</italic> remains constant. Here the mutation probability is 0.5 while the other parameters are detailed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>. <bold>(c-d)</bold> Simulations with different values of the basal birth rate. <bold>(e-f)</bold> Simulations with different population capacity <italic>N</italic>. <bold>(g-h)</bold> Simulations with different values of the variability coefficient D. <bold>(i-j)</bold> Simulation with different values of the death rate. (<bold>k-l</bold>) Simulation with BCR cluster of size 2. The variability coefficient taken here is D = 0.01, except for h. See details in <xref ref-type="supplementary-material" rid="pcbi.1006408.s002">S2 Text</xref> -“AM is largest for intermediate spike density”.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s005" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s005" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Selection and affinity maturation in a germinal center when the on-rate mutated and as a function of Ag encounter probability.</title>
<p>(<bold>a</bold>) Mean affinity of the dominant clone as a function of Ag density. <italic>q</italic> changes upon mutation while <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> remains constant. (<italic>p</italic> = 0.09). The overall range of change is larger when mutating <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> (<xref ref-type="fig" rid="pcbi.1006408.g002">Fig 2a</xref>) because small changes in the energy following mutation are exponentiated (<xref ref-type="disp-formula" rid="pcbi.1006408.e018">Eq (9)</xref>). (<bold>b</bold>) The fraction of the GC occupied by the dominant clone at day 16, where either <italic>q</italic> changes upon mutation while <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> remains constant (red), or vice versa (blue). (<bold>c-d</bold>) The BCR molecule does not diffuse freely in the synapse but performs confined stochastic motion, which depends on the interaction with the actin network [<xref ref-type="bibr" rid="pcbi.1006408.ref065">65</xref>]. Changing the search area of the BCR or its diffusion coefficient effectively changes the antigen encounter probability <italic>p</italic> (<xref ref-type="disp-formula" rid="pcbi.1006408.e001">Eq (1)</xref>). Mean occupation fraction (c) and affinity (d) of the dominant clone as a function of the probability that the Ag is within the scanning radius of the BCR (<italic>M</italic><sub><italic>Ag</italic></sub> = 10). Each point on the curves was obtained by averaging over 400 independent GC reactions. The parameter that accounts for the availability of TfhCs was set to an intermediate value of <italic>C</italic> = 75. The variability coefficient taken here is D = 0.01.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s006" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s006" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Accumulated affinity of B cells.</title>
<p>The mean affinity of a fraction of the B cells produces throughout the GCR. At each time point, we choose randomly 10% of the B cells in the GC. Their affinities were then averaged. The curve is a proxy for the affinities of memory and plasma B cells that would have been created during the GCR. The simulation parameters are detailed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s007" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s007" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Clonal diversity.</title>
<p>(<bold>a</bold>) The fraction of the GC occupied by the dominant clone at day 16, where <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> changes upon mutation while <italic>q</italic> remains constant. The simulation parameters are detailed in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref>. (<bold>b</bold>) The distribution of clonal dominance fraction for different GC realizations at days 1, 5, 10 and 16 of the GCR for <italic>n</italic><sub><italic>Ag</italic></sub> = 0.11.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s008" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s008" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Probability distribution of binding energy.</title>
<p>The energy distribution evolution in time for <italic>n</italic><sub><italic>Ag</italic></sub> = 0.13.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s009" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s009" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>The rate of affinity increase.</title>
<p>The mean on-rate <inline-formula id="pcbi.1006408.e024"><alternatives><graphic id="pcbi.1006408.e024g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e024" xlink:type="simple"/><mml:math display="inline" id="M24"><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> and variance <italic>σ</italic><sup>2</sup> calculated using Eqs (S25) and (S26) at different times, the parameters <italic>a</italic> = 0.77, <italic>b</italic> = 0.38, <italic>d</italic><sub>1</sub> = 0.2, <italic>d</italic><sub>2</sub> = 0.2, and <italic>D</italic> = 0.05 match the parameters in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref> and the initial on-rate is <inline-formula id="pcbi.1006408.e025"><alternatives><graphic id="pcbi.1006408.e025g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e025" xlink:type="simple"/><mml:math display="inline" id="M25"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. Each B cell has one BCR that has two arms. The time is in units of <italic>τ</italic><sub>0</sub>. We solve the equations for <italic>C</italic><sub>1</sub> = 1 (a,b) and <italic>C</italic><sub>1</sub> = 0.25 (c,d).</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s010" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s010" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>The rate of affinity increase for a BCR with one arm.</title>
<p><bold>(a)</bold> Scheme of a one arm BCR. Depicted are all the possible interaction states of the BCR and the Ag. (<bold>b-e</bold>) The mean on-rate calculated by solving numerically Eqs (S36,S39) at different times, the parameters <italic>a</italic> = 0.77, <italic>b</italic> = 0.38, <italic>d</italic><sub>1</sub> = 0.2, <italic>d</italic><sub>2</sub> = 0.2, and <italic>D</italic> = 0.05 that match the parameters in <xref ref-type="table" rid="pcbi.1006408.t002">Table 2</xref> while the initial on-rate is <inline-formula id="pcbi.1006408.e026"><alternatives><graphic id="pcbi.1006408.e026g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e026" xlink:type="simple"/><mml:math display="inline" id="M26"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. The time is in units of <italic>τ</italic><sub>0</sub>. We solve the equations for <italic>C</italic><sub>1</sub> = 1 with <italic>τ</italic> = 10(a), <italic>τ</italic> = 100(b) and <italic>C</italic><sub>1</sub> = 0.25 with <italic>τ</italic> = 10(c) and <italic>τ</italic> = 100(d).</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s011" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s011" xlink:type="simple">
<label>S8 Fig</label>
<caption>
<title>Mean affinity of B cells when the SD decreases with time.</title>
<p>The affinity of B cells at day 16 of the GCR when the spike density decays exponentially as <inline-formula id="pcbi.1006408.e027"><alternatives><graphic id="pcbi.1006408.e027g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1006408.e027" xlink:type="simple"/><mml:math display="inline" id="M27"><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>t</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>. The x-axis is the density at day zero of the competitive phase. Shown are the mean affinities when Ag does not decay (blue), <italic>T</italic><sub><italic>Ag</italic>−<italic>decay</italic></sub> = 16 days (yellow), and <italic>T</italic><sub><italic>Ag</italic>−<italic>decay</italic></sub> = 10 days (red).</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s012" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s012" xlink:type="simple">
<label>S9 Fig</label>
<caption>
<title>Dominance of clones following T helper cell restriction.</title>
<p>The fraction of the dominant clone in a GC depending on the amount of available Tfh cells (<italic>C</italic>). Different curves correspond to different values of spike density (<italic>n</italic><sub><italic>Ag</italic></sub>). <italic>E</italic><sub><italic>Ag</italic>−<italic>Ab</italic></sub> changes upon mutation in these simulations while <italic>q</italic> remains fixed.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1006408.s013" mimetype="application/eps" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1006408.s013" xlink:type="simple">
<label>S10 Fig</label>
<caption>
<title>The state of the BCR and the Ag.</title>
<p>Illustrated are all the possible states of the BCR and the Ag molecules. The notation is explained in the methods section.</p>
<p>(EPS)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The calculation in the section “<italic>Estimating the rate of affinity increase</italic>” is related to work by Molari and co-workers in a different context, which was shared with us by the authors (Modeling antibody affinity maturation under immunization protocols. Marco Molari, Simona Cocco and Rémi Monasson, in preparation).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1006408.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bouvier</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Palese</surname> <given-names>P</given-names></name>. <article-title>The biology of influenza viruses</article-title>. <source>Vaccine</source>. <year>2008</year>;<volume>26</volume>[<issue>SUPPL. 4</issue>]:<fpage>49</fpage>–<lpage>53</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mammen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>S-K</given-names></name>, <name name-style="western"><surname>Whitesides</surname> <given-names>GM</given-names></name>. <article-title>Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors</article-title>. <source>Angew Chemie Int Ed</source> [Internet]. <year>1998</year>;<volume>37</volume>[<issue>20</issue>]:<fpage>2754</fpage>–<lpage>94</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://doi.wiley.com/10.1002/%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3" xlink:type="simple">http://doi.wiley.com/10.1002/%28SICI%291521-3773%2819981102%2937%3A20%3C2754%3A%3AAID-ANIE2754%3E3.0.CO%3B2-3</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Galimidi</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Klein</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Politzer</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Bai</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Seaman</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Intra-spike crosslinking overcomes antibody evasion by HIV-1</article-title>. <source>Cell</source> [Internet]. Elsevier Inc.; <year>2015</year>;<volume>160</volume>[<issue>3</issue>]:<fpage>433</fpage>–<lpage>46</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2015.01.016" xlink:type="simple">http://dx.doi.org/10.1016/j.cell.2015.01.016</ext-link> <object-id pub-id-type="pmid">25635457</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Angeletti</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Angel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kosik</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hickman</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Frank</surname> <given-names>GM</given-names></name>, <etal>et al</etal>. <article-title>Defining B cell immunodominance to viruses</article-title>. <source>Nat Immunol</source> [Internet]. <year>2017</year>;<volume>18</volume>[<issue>4</issue>]:<fpage>456</fpage>–<lpage>63</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/doifinder/10.1038/ni.3680" xlink:type="simple">http://www.nature.com/doifinder/10.1038/ni.3680</ext-link> <object-id pub-id-type="pmid">28192417</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamaguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Danev</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nishiyama</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sugawara</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nagayama</surname> <given-names>K</given-names></name>. <article-title>Zernike phase contrast electron microscopy of ice-embedded influenza A virus</article-title>. <source>J Struct Biol</source>. <year>2008</year>;<volume>162</volume>[<issue>2</issue>]:<fpage>271</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsb.2008.01.009" xlink:type="simple">10.1016/j.jsb.2008.01.009</ext-link></comment> <object-id pub-id-type="pmid">18313941</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Merz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hiet</surname> <given-names>M-S</given-names></name>, <name name-style="western"><surname>Brügger</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Chlanda</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Andre</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome</article-title>. <source>J Biol Chem</source> [Internet]. <year>2011</year>;<volume>286</volume>[<issue>4</issue>]:<fpage>3018</fpage>–<lpage>32</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21056986%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3024796" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/21056986%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3024796</ext-link> <object-id pub-id-type="pmid">21056986</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Chertova</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bess</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lifson</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Arthur</surname> <given-names>LO</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions</article-title>. <source>Proc Natl Acad Sci U S A</source> [Internet]. <year>2003</year>;<volume>100</volume>[<issue>26</issue>]:<fpage>15812</fpage>–<lpage>7</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/14668432%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC307650" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/14668432%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC307650</ext-link> <object-id pub-id-type="pmid">14668432</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riedel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vasishtan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Siebert</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Whittle</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lehmann</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Mothes</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Native structure of a retroviral envelope protein and its conformational change upon interaction with the target cell</article-title>. <source>J Struct Biol</source> [Internet]. The Author(s); <year>2017</year>;<volume>197</volume>[<issue>2</issue>]:<fpage>172</fpage>–<lpage>80</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jsb.2016.06.017" xlink:type="simple">http://dx.doi.org/10.1016/j.jsb.2016.06.017</ext-link> <object-id pub-id-type="pmid">27345930</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forster</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Medalia</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Zauberman</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Baumeister</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Fass</surname> <given-names>D</given-names></name>. <article-title>Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography</article-title>. <source>Proc Natl Acad Sci</source> [Internet]. <year>2005</year>;<volume>102</volume>[<issue>13</issue>]:<fpage>4729</fpage>–<lpage>34</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/cgi/doi/10.1073/pnas.0409178102" xlink:type="simple">http://www.pnas.org/cgi/doi/10.1073/pnas.0409178102</ext-link> <object-id pub-id-type="pmid">15774580</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dolnik</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Volchkova</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Garten</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Carbonnelle</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kahnt</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Ectodomain shedding of the glycoprotein GP of Ebola virus</article-title>. <source>EMBO J</source>. <year>2004</year>;<volume>23</volume>[<issue>10</issue>]:<fpage>2175</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.emboj.7600219" xlink:type="simple">10.1038/sj.emboj.7600219</ext-link></comment> <object-id pub-id-type="pmid">15103332</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stano</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Leaman</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Autin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ingale</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Dense array of spikes on HIV-1 virion particles</article-title>. <source>J Virol</source> [Internet]. <year>2017</year>;[<month>April</month>]:JVI.00415-17. Available from: <ext-link ext-link-type="uri" xlink:href="http://jvi.asm.org/lookup/doi/10.1128/JVI.00415-17" xlink:type="simple">http://jvi.asm.org/lookup/doi/10.1128/JVI.00415-17</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Victora</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname> <given-names>MC</given-names></name>. <article-title>Germinal centers</article-title>. <source>Annu Rev Immunol</source> [Internet]. <year>2012</year>;<volume>30</volume>:<fpage>429</fpage>–<lpage>57</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22224772%5Cnhttp://www.annualreviews.org/doi/pdf/10.1146/annurev-immunol-020711-075032" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/22224772%5Cnhttp://www.annualreviews.org/doi/pdf/10.1146/annurev-immunol-020711-075032</ext-link> <object-id pub-id-type="pmid">22224772</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eisen</surname> <given-names>HN</given-names></name>, <name name-style="western"><surname>Siskind</surname> <given-names>GW</given-names></name>. <article-title>Variations in Affinities of Antibodies During the Immune Response</article-title>. <source>Biochemistry</source> [Internet]. <year>1964</year>;<volume>3</volume>[<issue>1959</issue>]:<fpage>996</fpage>–<lpage>1008</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/14214095" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/14214095</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>YS</given-names></name>. <article-title>How do follicular dendritic cells interact intimately with B cells in the germinal centre?</article-title> <source>Immunology</source>. <year>2005</year>;<volume>114</volume>[<issue>1</issue>]:<fpage>2</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2567.2004.02075.x" xlink:type="simple">10.1111/j.1365-2567.2004.02075.x</ext-link></comment> <object-id pub-id-type="pmid">15606789</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carrasco</surname> <given-names>YR</given-names></name>, <name name-style="western"><surname>Batista</surname> <given-names>FD</given-names></name>. <article-title>B Cells Acquire Particulate Antigen in a Macrophage-Rich Area at the Boundary between the Follicle and the Subcapsular Sinus of the Lymph Node</article-title>. <source>Immunity</source>. <year>2007</year>;<volume>27</volume>[<issue>1</issue>]:<fpage>160</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2007.06.007" xlink:type="simple">10.1016/j.immuni.2007.06.007</ext-link></comment> <object-id pub-id-type="pmid">17658276</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rolf</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bell</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Kovesdi</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Michelle</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Soond</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Webb</surname> <given-names>LMC</given-names></name>, <etal>et al</etal>. <article-title>Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction</article-title>. <source>J Immunol</source> [Internet]. <year>2010</year>;<volume>185</volume>[<issue>7</issue>]:<fpage>4042</fpage>–<lpage>52</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20826752" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/20826752</ext-link> <object-id pub-id-type="pmid">20826752</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gitlin</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Mayer</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Oliveira</surname> <given-names>TY</given-names></name>, <name name-style="western"><surname>Shulman</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>MJK</given-names></name>, <name name-style="western"><surname>Koren</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>T cell help controls the speed of the cell cycle in germinal center B cells</article-title>. <source>Science (80-)</source> [Internet]. <year>2015</year>;<volume>349</volume>[<issue>July</issue>]:<fpage>643</fpage>–<lpage>6</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sciencemag.org/cgi/doi/10.1126/science.aac4919" xlink:type="simple">http://www.sciencemag.org/cgi/doi/10.1126/science.aac4919</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Victora</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Schwickert</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Fooksman</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Kamphorst</surname> <given-names>AO</given-names></name>, <name name-style="western"><surname>Meyer-Hermann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dustin</surname> <given-names>ML</given-names></name>, <etal>et al</etal>. <article-title>Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter</article-title>. <source>Cell</source> [Internet]. Elsevier Ltd; <year>2010</year>;<volume>143</volume>[<issue>4</issue>]:<fpage>592</fpage>–<lpage>605</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2010.10.032" xlink:type="simple">http://dx.doi.org/10.1016/j.cell.2010.10.032</ext-link> <object-id pub-id-type="pmid">21074050</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oprea</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Perelson</surname> <given-names>AS</given-names></name>. <article-title>Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts</article-title>. <source>J Immunol</source> [Internet]. <year>1997</year>;<volume>158</volume>[<issue>11</issue>]:<fpage>5155</fpage>–<lpage>62</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9164931" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/9164931</ext-link> <object-id pub-id-type="pmid">9164931</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kepler</surname> <given-names>TB</given-names></name>, <name name-style="western"><surname>Perelson</surname> <given-names>aS</given-names></name>. <article-title>Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation</article-title>. <source>Immunol Today</source>. <year>1993</year>;<volume>14</volume>[<issue>8</issue>]:<fpage>412</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0167-5699(93)90145-B" xlink:type="simple">10.1016/0167-5699(93)90145-B</ext-link></comment> <object-id pub-id-type="pmid">8397781</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chaudhury</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Reifman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wallqvist</surname> <given-names>A</given-names></name>. <article-title>Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1</article-title>. <source>J Immunol</source>. <year>2014</year>;<volume>193</volume>[<issue>5</issue>]:<fpage>2073</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1401054" xlink:type="simple">10.4049/jimmunol.1401054</ext-link></comment> <object-id pub-id-type="pmid">25080483</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mata-Fink</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kriegsman</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hanson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Irvine</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Eisen</surname> <given-names>HN</given-names></name>, <etal>et al</etal>. <article-title>Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies</article-title>. <source>Cell</source> [Internet]. Elsevier Inc.; <year>2015</year>;<volume>160</volume>[<issue>4</issue>]:<fpage>785</fpage>–<lpage>97</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2015.01.027" xlink:type="simple">http://dx.doi.org/10.1016/j.cell.2015.01.027</ext-link> <object-id pub-id-type="pmid">25662010</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Figge</surname> <given-names>MT</given-names></name>. <article-title>Stochastic discrete event simulation of germinal center reactions</article-title>. <source>Phys Rev E—Stat Nonlinear, Soft Matter Phys</source>. <year>2005</year>;<volume>71</volume>[<issue>5</issue>]:<fpage>1</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Shakhnovich</surname> <given-names>EI</given-names></name>. <article-title>Optimality of mutation and selection in germinal centers</article-title>. <source>PLoS Comput Biol</source> [Internet]. <year>2010</year>;<volume>6</volume>[<issue>6</issue>]:<fpage>e1000800</fpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2880589&amp;tool=pmcentrez&amp;rendertype=abstract" xlink:type="simple">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2880589&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> <object-id pub-id-type="pmid">20532164</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meyer-Hermann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mohr</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pelletier</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Victora</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Toellner</surname> <given-names>KM</given-names></name>. <article-title>A theory of germinal center b cell selection, division, and exit</article-title>. <source>Cell Rep</source>. <year>2012</year>;<volume>2</volume>[<issue>1</issue>]:<fpage>162</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2012.05.010" xlink:type="simple">10.1016/j.celrep.2012.05.010</ext-link></comment> <object-id pub-id-type="pmid">22840406</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nowosad</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Spillane</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Tolar</surname> <given-names>P</given-names></name>. <article-title>Germinal center B cells recognize antigen through a specialized immune synapse architecture</article-title>. <source>Nat Immunol</source> [Internet]. Nature Publishing Group; <year>2016</year>;<volume>17</volume>[<issue>May</issue>]:<fpage>1</fpage>–<lpage>11</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/doifinder/10.1038/ni.3458%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/27183103" xlink:type="simple">http://www.nature.com/doifinder/10.1038/ni.3458%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/27183103</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref027"><label>27</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Tolar</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Spillane</surname> <given-names>KM</given-names></name>. <chapter-title>Force generation in B-cell synapses: Mechanisms coupling B-cell receptor binding to antigen internalization and affinity discrimination</chapter-title> [Internet]. <edition>1st ed</edition>. <source>Advances in Immunology</source>. <publisher-name>Elsevier Inc</publisher-name>.; <year>2014</year>. <fpage>69</fpage>–<lpage>100</lpage> p. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/B978-0-12-800266-7.00002-9" xlink:type="simple">http://dx.doi.org/10.1016/B978-0-12-800266-7.00002-9</ext-link> <object-id pub-id-type="pmid">24840948</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jacob</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Przylepa</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kelsoe</surname> <given-names>G</given-names></name>. <article-title>In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells</article-title>. <source>J Exp Med</source> [Internet]. <year>1993</year>;<volume>178</volume>[<issue>4</issue>]:<fpage>1293</fpage>–<lpage>307</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/doi/10.1084/jem.178.4.1293%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2191212&amp;tool=pmcentrez&amp;rendertype=abstract" xlink:type="simple">http://www.jem.org/cgi/doi/10.1084/jem.178.4.1293%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2191212&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> <object-id pub-id-type="pmid">8376935</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gitlin</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Shulman</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname> <given-names>MC</given-names></name>. <article-title>Clonal selection in the germinal centre by regulated proliferation and hypermutation</article-title>. <source>Nature</source> [Internet]. Nature Publishing Group; <year>2014</year>;<volume>509</volume>[<issue>7502</issue>]:<fpage>637</fpage>–<lpage>40</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/24805232" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/24805232</ext-link> <object-id pub-id-type="pmid">24805232</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shulman</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Gitlin</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Weinstein</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Lainez</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Esplugues</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Flavell</surname> <given-names>RA</given-names></name>, <etal>et al</etal>. <article-title>Dynamic signaling by T follicular helper cells during germinal center B cell selection</article-title>. <source>Science (80-)</source>. <year>2014</year>;<volume>345</volume>[<issue>6200</issue>].</mixed-citation></ref>
<ref id="pcbi.1006408.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tas</surname> <given-names>JMJ</given-names></name>, <name name-style="western"><surname>Mesin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pasqual</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Targ</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jacobsen</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Mano</surname> <given-names>YM</given-names></name>, <etal>et al</etal>. <article-title>Visualizing antibody affinity maturation in germinal centers</article-title>. <source>Science (80-)</source> [Internet]. <year>2016</year>;<volume>58</volume>[<issue>12</issue>]:<fpage>7250</fpage>–<lpage>7</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25246403" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/25246403</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Depoil</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zaru</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Guiraud</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chauveau</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Harriague</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bismuth</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Immunological synapses are versatile structures enabling selective T cell polarization</article-title>. <source>Immunity</source>. <year>2005</year>;<volume>22</volume>[<issue>2</issue>]:<fpage>185</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2004.12.010" xlink:type="simple">10.1016/j.immuni.2004.12.010</ext-link></comment> <object-id pub-id-type="pmid">15723807</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Vinuesa</surname> <given-names>CG</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Ball</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Drew</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sunners</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cascalho</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Germinal centers without T cells</article-title>. <source>J Exp Med</source> [Internet]. <year>2000</year>;<volume>191</volume>[<issue>3</issue>]:<fpage>485</fpage>–<lpage>94</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/10662794%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2195827" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/10662794%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2195827</ext-link> <object-id pub-id-type="pmid">10662794</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morgan</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Dean</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Coker</surname> <given-names>HA</given-names></name>, <name name-style="western"><surname>Reik</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Petersen-Mahrt</surname> <given-names>SK</given-names></name>. <article-title>Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>[<issue>50</issue>]:<fpage>52353</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M407695200" xlink:type="simple">10.1074/jbc.M407695200</ext-link></comment> <object-id pub-id-type="pmid">15448152</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amitai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mesin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Victora</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Kardar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chakraborty</surname> <given-names>AK</given-names></name>. <article-title>A population dynamics model for clonal diversity in a germinal center</article-title>. <source>Front Microbiol</source>. <year>2017</year>;<volume>8</volume>[<issue>SEP</issue>].</mixed-citation></ref>
<ref id="pcbi.1006408.ref036"><label>36</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Fisher</surname> <given-names>RA</given-names></name>. <source>The Genetical Theory of Natural Selection: A Complete Variorum Edition</source>. <name name-style="western"><surname>Bennet</surname> <given-names>JH</given-names></name>, editor. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2000</year>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname> <given-names>GR</given-names></name>. <article-title>Selection and covariance</article-title>. <source>Nature</source>. <year>1970</year>;<volume>227</volume>[<issue>5257</issue>]:<fpage>520</fpage>–<lpage>521</lpage>. <object-id pub-id-type="pmid">5428476</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okoye</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Picker</surname> <given-names>LJ</given-names></name>. <article-title>CD4+ T-Cell Depletion In Hiv Infection: Mechanisms Of Immunological Failure</article-title>. <source>Immunol Rev</source>. <year>2013</year>;<volume>254</volume>[<issue>1</issue>]:<fpage>54</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/imr.12066" xlink:type="simple">10.1111/imr.12066</ext-link></comment> <object-id pub-id-type="pmid">23772614</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Satou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Matsuoka</surname> <given-names>M</given-names></name>. <article-title>Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1</article-title>. <source>Rev Med Virol</source> [Internet]. <year>2013</year> <month>Sep</month> <day>1</day> [cited 2017 Oct 24];<volume>23</volume>[<issue>5</issue>]:<fpage>269</fpage>–<lpage>80</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://doi.wiley.com/10.1002/rmv.1745" xlink:type="simple">http://doi.wiley.com/10.1002/rmv.1745</ext-link> <object-id pub-id-type="pmid">23606621</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Motai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Takachi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Higuchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hara</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mizuguchi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB</article-title>. <source>Virus Genes</source> [Internet]. Springer US; <year>2016</year> <month>Feb</month> <day>6</day> [cited 2017 Oct 24];<volume>52</volume>[<issue>1</issue>]:<fpage>4</fpage>–<lpage>13</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://link.springer.com/10.1007/s11262-015-1277-7" xlink:type="simple">http://link.springer.com/10.1007/s11262-015-1277-7</ext-link> <object-id pub-id-type="pmid">26739459</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zingler</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Littman</surname> <given-names>DR</given-names></name>. <article-title>Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity</article-title>. <source>J Virol</source> [Internet]. <year>1993</year>;<volume>67</volume>[<issue>5</issue>]:<fpage>2824</fpage>–<lpage>31</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8474176%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC237607" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/8474176%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC237607</ext-link> <object-id pub-id-type="pmid">8474176</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schiller</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chackerian</surname> <given-names>B</given-names></name>. <article-title>Why HIV Virions Have Low Numbers of Envelope Spikes: Implications for Vaccine Development</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>[<issue>8</issue>]:<fpage>8</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klein</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Bjorkman</surname> <given-names>PJ</given-names></name>. <article-title>Few and far between: How HIV may be evading antibody avidity</article-title>. <source>PLoS Pathog</source>. <year>2010</year>;<volume>6</volume>[<issue>5</issue>]:<fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Meyer-Hermann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>George</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Figge</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Goodall</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Germinal center B cells govern their own fate via antibody feedback</article-title>. <source>J Exp Med</source>. <year>2013</year>;<volume>210</volume>[<issue>3</issue>]:<fpage>457</fpage>–<lpage>64</lpage>. <object-id pub-id-type="pmid">23420879</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McFarland</surname> <given-names>HF</given-names></name>. <article-title>The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity</article-title>. <source>J Immunol</source> [Internet]. <year>1974</year>;<volume>113</volume>[<issue>6</issue>]:<fpage>1978</fpage>–<lpage>83</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=4139203" xlink:type="simple">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=4139203</ext-link> <object-id pub-id-type="pmid">4139203</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Auwaerter</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Rota</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Elkins</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>DeLozier</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>180</volume>[<issue>4</issue>]:<fpage>950</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">10479117</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Griffin</surname> <given-names>DE</given-names></name>. <article-title>The immune response in measles: Virus control, clearance and protective immunity</article-title>. <source>Viruses</source>. <year>2016</year>;<volume>8</volume>[<issue>10</issue>].</mixed-citation></ref>
<ref id="pcbi.1006408.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Popovic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Flomenberg</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Volkman</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Mann</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Fauci</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Dupont</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Alteration of T-cell functions by infection with HTLV-I or HTLV-II</article-title>. <source>Science (80-)</source> [Internet]. <year>1984</year>;<volume>226</volume>[<issue>4673</issue>]:<fpage>459</fpage>–<lpage>62</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=6093248" xlink:type="simple">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=6093248</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Igakura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Stinchcombe</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Goon</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Griffiths</surname> <given-names>GM</given-names></name>, <etal>et al</etal>. <article-title>Spread of HTLV-1 Between Lymphocytes by Virus-Induced Polarization of the Cytoskeletion</article-title>. <source>Science (80-)</source> [Internet]. <year>2003</year>;<volume>299</volume>[<issue>2003</issue>]:<fpage>1713</fpage>–<lpage>6</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://science.sciencemag.org/content/299/5613/1713" xlink:type="simple">http://science.sciencemag.org/content/299/5613/1713</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feuer</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Green</surname> <given-names>PL</given-names></name>. <article-title>Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2</article-title>. <source>Oncogene</source>. <year>2005</year>;<volume>24</volume>[<issue>39</issue>]:<fpage>5996</fpage>–<lpage>6004</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.onc.1208971" xlink:type="simple">10.1038/sj.onc.1208971</ext-link></comment> <object-id pub-id-type="pmid">16155606</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cao</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Maldonado</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Grigsby</surname> <given-names>IF</given-names></name>, <name name-style="western"><surname>Mansky</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>. <article-title>Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography</article-title>. <source>J Virol</source> [Internet]. <year>2015</year>;<volume>89</volume>[<issue>4</issue>]:<fpage>2430</fpage>–<lpage>5</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.scopus.com/inward/record.url?eid=2-s2.0-84921632829&amp;partnerID=tZOtx3y1" xlink:type="simple">http://www.scopus.com/inward/record.url?eid=2-s2.0-84921632829&amp;partnerID=tZOtx3y1</ext-link> <object-id pub-id-type="pmid">25473052</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crooks</surname> <given-names>ET</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Franti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zwick</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Hoxie</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization</article-title>. <source>Virology</source>. <year>2008</year>;<volume>377</volume>[<issue>2</issue>]:<fpage>364</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virol.2008.04.045" xlink:type="simple">10.1016/j.virol.2008.04.045</ext-link></comment> <object-id pub-id-type="pmid">18539308</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edgeworth</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Freemont</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hogg</surname> <given-names>N</given-names></name>. <article-title>siv adaptation to human cells</article-title>. <source>Nature</source>. <year>1989</year>;<volume>342</volume>:<fpage>189</fpage>–<lpage>92</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chakrabarti</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Emerman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tiollais</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sonigo</surname> <given-names>P</given-names></name>. <article-title>The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity</article-title>. <source>J Virol</source>. <year>1989</year>;<volume>63</volume>[<issue>10</issue>]:<fpage>4395</fpage>–<lpage>403</lpage>. <object-id pub-id-type="pmid">2778881</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kodama</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wooley</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Naidu</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Kestler</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Daniel</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Significance of premature stop codons in env of simian immunodeficiency virus</article-title>. <source>J Virol</source> [Internet]. <year>1989</year>;<volume>63</volume>[<issue>11</issue>]:<fpage>4709</fpage>–<lpage>14</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=251107&amp;tool=pmcentrez&amp;rendertype=abstract" xlink:type="simple">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=251107&amp;tool=pmcentrez&amp;rendertype=abstract</ext-link> <object-id pub-id-type="pmid">2795718</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dintzis</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Dintzis</surname> <given-names>RZ</given-names></name>, <name name-style="western"><surname>Vogelstein</surname> <given-names>B</given-names></name>. <article-title>Molecular determinants of immunogenicity: the immunon model of immune response</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1976</year>;<volume>73</volume>[<issue>10</issue>]:<fpage>3671</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">62364</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ingale</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stano</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Guenaga</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sharma</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Nemazee</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zwick</surname> <given-names>MB</given-names></name>, <etal>et al</etal>. <article-title>High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells</article-title>. <source>Cell Rep</source> [Internet]. The Author(s); <year>2016</year>;<volume>15</volume>[<issue>9</issue>]:<fpage>1986</fpage>–<lpage>99</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2016.04.078" xlink:type="simple">http://dx.doi.org/10.1016/j.celrep.2016.04.078</ext-link> <object-id pub-id-type="pmid">27210756</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hadzhieva</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pashov</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Kaveri</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lacroix-Desmazes</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mouquet</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Dimitrov</surname> <given-names>JD</given-names></name>. <article-title>Impact of Antigen Density on the Binding Mechanism of IgG Antibodies. Sci Rep</article-title> [Internet]. <year>2017</year>;<volume>7</volume>[<issue>1</issue>]:<fpage>3767</fpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/articles/s41598-017-03942-z" xlink:type="simple">http://www.nature.com/articles/s41598-017-03942-z</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nåsell</surname> <given-names>I</given-names></name>. <article-title>Extinction and quasi-stationarity in the Verhulst logistic model</article-title>. <source>J Theor Biol</source> [Internet]. <year>2001</year>;<volume>211</volume>[<issue>1</issue>]:<fpage>11</fpage>–<lpage>27</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11407888" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/11407888</ext-link> <object-id pub-id-type="pmid">11407888</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bell</surname> <given-names>G</given-names></name>. <article-title>Models for the specific adhesion of cells to cells</article-title>. <source>Science (80-)</source> [Internet]. <year>1978</year>;<volume>200</volume>[<issue>4342</issue>]:<fpage>618</fpage>–<lpage>27</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.sciencemag.org/cgi/doi/10.1126/science.347575" xlink:type="simple">http://www.sciencemag.org/cgi/doi/10.1126/science.347575</ext-link></mixed-citation></ref>
<ref id="pcbi.1006408.ref061"><label>61</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Schuss</surname> <given-names>Z</given-names></name>. <chapter-title>Diffusion and Stochastic Processes</chapter-title>. <source>An Analytical Approach</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>; <year>2009</year>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gru</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Desai</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Winkler</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Heymann</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Belnap</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Baumeister</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Three-Dimensional Structure of Herpes Simplex Virus from Cryo—Electron Tomography</article-title>. <source>Science (80-)</source>. <year>2003</year>;<volume>302</volume>[<issue>November</issue>]:<fpage>1396</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pcbi.1006408.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Sheng</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Hoornweg</surname> <given-names>TE</given-names></name>, <name name-style="western"><surname>Smit</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kuhn</surname> <given-names>RJ</given-names></name>, <etal>et al</etal>. <article-title>Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers</article-title>. <source>J Virol</source> [Internet]. <year>2015</year>;<volume>89</volume>[<issue>1</issue>]:<fpage>743</fpage>–<lpage>50</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25355881%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4301137" xlink:type="simple">http://www.ncbi.nlm.nih.gov/pubmed/25355881%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4301137</ext-link> <object-id pub-id-type="pmid">25355881</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prasad</surname> <given-names>VM</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Klose</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sirohi</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Buda</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Structure of the immature Zika virus at 9 Å resolution</article-title>. <source>Nat Struct Mol Biol</source> [Internet]. Nature Publishing Group; <year>2017</year>;<volume>24</volume>[<issue>2</issue>]:<fpage>184</fpage>–<lpage>6</lpage>. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/doifinder/10.1038/nsmb.3352" xlink:type="simple">http://www.nature.com/doifinder/10.1038/nsmb.3352</ext-link> <object-id pub-id-type="pmid">28067914</object-id></mixed-citation></ref>
<ref id="pcbi.1006408.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Batista</surname> <given-names>FD</given-names></name>, <name name-style="western"><surname>Treanor</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Harwood</surname> <given-names>NE</given-names></name>. <article-title>Visualizing a role for the actin cytoskeleton in the regulation of B-cell activation</article-title>. <source>Immunol Rev</source>. <year>2010</year>;<volume>237</volume>[<issue>1</issue>]:<fpage>191</fpage>–<lpage>204</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>